On April 12, 2021, the Acting Director of the
Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement regarding the accounting and reporting
considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting
Considerations for Warrants Issued by Special Purpose Acquisition Companies(“SPACs”)” (the “SEC Statement”).
Specifically, the SEC Statement focused on certain provisions that provided for potential changes to the settlement amounts dependent
upon the characteristics of the holder of the warrant, which terms are similar to those contained in the warrant agreement governing the
Company’s warrants. As a result of the SEC Statement, on December 21, 2021, the Company reevaluated the accounting treatment of
the 5,750,000 warrants that were issued in the Initial Public Offering (the “Public Warrants”). The Company previously accounted
for the Public Warrants as components of derivative liabilities.
As a result of the above, the Company should have
classified the Public warrants as component of equity in its previously issued financial statements. The Company’s accounting for
the Public warrants as derivative liabilities instead of as components of equity did not have any effect on the Company’s previously
reported operating expenses or cash.
In addition, in accordance with the SEC and
its staff’s guidance on redeemable equity instruments, ASC Topic 480, Distinguishing Liabilities from Equity (ASC 480),
paragraph 10-S99, redemption provisions not solely within the control of the Company require ordinary share subject to redemption to
be classified outside of permanent equity. The Company had previously classified a portion of its ordinary share in permanent
equity. Although the Company did not specify a maximum redemption threshold, its charter provides that currently, the Company will
not redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001. The Company
considered that the threshold would not change the nature of the underlying shares as redeemable and thus would be required to be
disclosed outside equity. As a result, the Company’s previously issued (i) audited balance sheet as of March 4, 2021 included
in the Company’s Current Report on Form 8-K/A filed with the SEC on May 17, 2021, (ii) audited financial statements as of June
30, 2021 and for the year ended June 30, 2021 filed with the SEC on September 1, 2021, (iii) unaudited interim financial statements
as of March 31, 2021 and for the three and nine months ended March 31, 2021 included in the Company’s Quarterly Report on Form
10-Q filed with the SEC on May 17, 2021 (collectively, the “Affected Periods”), in each case, should be corrected to all
of the Public Shares as temporary equity and should no longer be relied upon.
In connection with the restatement, the Company’s
management reassessed the effectiveness of its disclosure controls and procedures for the periods affected by the restatement. As a result
of that reassessment, the Company’s management determined that its disclosure controls and procedures for such periods were not
effective due to two material weaknesses in internal control over financial reporting related to the classification of the Company’s
warrants as components of equity instead of as derivative liabilities and the allocation and treatment of the initial transaction costs
of the initial public offering. For more information, see Item 9A included in this Annual Report on Form 10-K/A.
The Company has reflected these corrections in its Quarterly Report
on Form 10-Q for the quarterly period ended September 30, 2021, filed with SEC on November 15, 2021 (the “November 2021 Form 10-Q”).
The Company does not expect the changes described above to have any impact on its cash position or the balance held in the trust account.
The Company has not amended its previously filed Quarterly Reports on Form 10-Q or Current Reports on Form 8-K for the period affected
by the restatement. The financial information that has been previously filed or otherwise reported for these periods is superseded by
the information in this Annual Report on Form 10-K/A, and the financial statements and related financial information contained in such
previously filed reports should no longer be relied upon.
The restatement is more fully described in Note 2 of the notes to the
consolidated financial statements included herein.
This Amendment No. 1 presents the Original Filling, amended and
restated with modifications as necessary to reflect the restatements.
ITEM
1. BUSINESS
Introduction
Goldenbridge Acquisition Limited is a British
Virgin Islands exempted company incorporated on August 12, 2019 as a blank check company for the purpose of entering into a merger, share
exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more
target businesses. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region,
although we currently intend to focus on opportunities in the artificial intelligence and any other related technology innovations market.
On March 4, 2021, the Company consummated the
initial public offering (“IPO”) of 5,000,000 units (the “Units”). Each Unit consists of one ordinary share (“Ordinary
Share”), one warrant (“Warrant”) entitling its holder to purchase one-half of one Ordinary Share at a price of $11.50
per whole share, and one right to receive one-tenth (1/10) of an Ordinary Share upon the consummation of an initial business combination.
The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $50,000,000. The Company granted the underwriters
a 45-day option to purchase up to 750,000 additional Units to cover over-allotments, if any. In addition, the Company sold to Maxim Group LLC
(“Maxim”), for $100, an option to purchase up to 375,000 units exercisable at $11.50 per unit, commencing on the later of
the consummation of a business combination and six months from the effective date of the Registration Statement.
Simultaneously with the consummation of the IPO,
we consummated the private placement (“Private Placement”) with our Sponsor of 350,000 units (the “Private Units”)
at a price of $10.00 per Private Unit, generating gross proceeds of $3,500,000. The Private Units are identical to the Units sold in the
IPO, except that the warrants underlying the Private Units will be non-redeemable and may be exercised on a cashless basis, in each case
so long as they continue to be held by the initial purchasers or their permitted transferees. Additionally, because the Private Units
were issued in a private transaction, the initial purchasers and their permitted transferees will be allowed to exercise the warrants
included in the Private Units for cash even if a registration statement covering the ordinary shares issuable upon exercise of such warrants
is not effective and receive unregistered ordinary shares. Additionally, such initial purchasers agreed not to transfer, assign or sell
any of the Private Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until
the completion of the Company’s initial business combination. Such Initial Purchasers were granted certain demand and piggyback
registration rights in connection with the purchase of the Private Units. The Private Units were issued pursuant to Section 4(a)(2) of
the Securities Act of 1933, as amended, as the transactions did not involve a public offering.
The underwriters exercised the over-allotment
option in full on March 9, 2021, and the closing of the issuance and sale of the additional Units occurred on March 11, 2021. The sale
of 750,000 units at a price of $10.00 per unit resulted in total gross proceeds of $7,500,000.
A total of $57,500,000 of the net proceeds from
the sale of Units in the IPO (including the over-allotment option units) and the private placements on March 4, 2021 and March 11, 2021,
were placed in a trust account established for the benefit of the Company’s public shareholders at Morgan Stanley maintained by
Continental Stock Transfer & Trust Company, LLC, acting as trustee. None of the funds held in trust will be released from the trust
account, other than interest income to pay any tax obligations, until the earlier of the completion of an initial business combination
within the required time period or our entry into liquidation if we have not completed a business combination in the required time period.
On April 6, 2021, our ordinary shares, warrants and rights underlying the Units sold in our IPO began to trade separately on a voluntary
basis.
Since our IPO, our sole business activity has
been identifying and evaluating suitable acquisition transaction candidates.
Management is currently evaluating the impact
of the COVID-19 global pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative
effect on the Company’s consolidated financial position, results of its operations, close of the Initial Public Offering and/or
search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements.
The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Our Management Team
We will seek to capitalize on the comprehensive
experience and contacts of our executive officers in consummating an initial business combination. Our management team is comprised of
Yongsheng Liu, Chairman and Chief Executive Officer, Yanhong Xue, our Chief Financial Officer, and Ray Chen, our Chief Operating Officer.
Our management team brings a wealth of experience in identifying, negotiating with and conducting due diligence on potential candidates
for acquisition.
Mr. Liu and Mr. Chen have experience with initial
public offerings and business combinations for blank check companies. They have worked together on the formation, initial public offering
and business combination for Wealthbridge Acquisition Limited (“Wealthbridge”). Mr. Liu served as Chief Executive Officer
and Chairman of Wealthbridge which consummated an initial public offering in February 2019 and closed its business combination with Scienjoy
Inc. (“Scienjoy”) in May 2020, and has been serving as vice chairman of Scienjoy’s board of director since May 2020.
Mr. Chen served as Chief Operating Officer of Wealthbridge until May 2020 and currently serves as investor relation consultant of Scienjoy.
Mr. Liu has over 10 years of experience in mergers
and acquisitions, including cross-border transactions involving the United States and China, which Mr. Liu actively participated in (in
a variety capacities) from initial deal sourcing and negotiations through consummation. Mr. Chen also has over 10 years of extensive experience
with mergers and acquisitions, especially with respect to target sourcing, deal structuring, and investment relations. Our Chief Financial
Officer, Ms. Xue, has over 20 years of extensive experience in financial reporting, financial due diligence, U.S. public companies and
post-merger rule compliance and her connections to investments and businesses operated by ethnic minorities in U.S., which we believe,
will be a source of potential targets for us.
With a management team with experience in merger
and acquisitions for blank check companies, connections to the Asian-American community in the United States, and experience in business
development, we believe we can source attractive deals and find compelling investment opportunities from private and public sources to
create value for shareholders. See the section titled “Management” for complete information on the experience of our
officers and directors.
Notwithstanding the foregoing, our officers and
directors are not required to commit their full time to our affairs and will allocate their time to other businesses, which may result
in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses.
We presently expect each of our employees to devote such amount of time as they reasonably believe is necessary to our business (which
could range from only a few hours a week while we are trying to locate a potential target business to a majority of their time as we move
into serious negotiations with a target business for a business combination). As more fully discussed in “Management —
Conflicts of Interest,” if any of our officers or directors becomes aware of a business combination opportunity that falls within
the line of business of any entity to which he has pre-existing fiduciary or contractual obligations, he may be required to present such
business combination opportunity to such entity, subject to his or her fiduciary duties under the British Virgin Islands law, prior to
presenting such business combination opportunity to us. Most of our officers and directors currently have certain pre-existing fiduciary
duties or contractual obligations.
In addition, past performance by our management
team is not a guarantee either (i) of success with respect to any business combination we may consummate or (ii) that we will be able
to locate a suitable candidate for our initial business combination. Furthermore, the members of the management team may not remain with
us subsequent to the consummation of a business combination.
Competitive Advantages
Experienced Management Team with Proven Track
Record
Our management team has a proven track record
of successful executing business combination and generating attractive return for investors as evidenced by the completion of business
combination between Wealthbridge and Scienjoy in May 2020.
Together with our management team, we believe
we have a broad network of contacts and corporate relationship that makes us efficient at:
|
●
|
Sourcing and evaluating businesses, and
|
|
●
|
Bridging cultural differences to negotiate and execute a transaction in a timely and professional manner
|
By leveraging our management team’s industry
expertise, performing disciplined due diligence, being cautious downside protection, and providing post-acquisition value-add capabilities,
we believe that we will be able to acquire a target business that will achieve significant returns for investors.
Status as a Publicly Listed Company
We believe our structure will make us an attractive
business combination partner to prospective target businesses. As a publicly listed company, we will offer a target business an alternative
to the traditional initial public offering. We believe that target businesses will favor this alternative, which we believe is less expensive,
while offering greater certainty of execution than the traditional initial public offering. During an initial public offering, there are
typically expenses incurred in marketing, which would be costlier than a business combination with us. Furthermore, once a proposed business
combination is approved by our shareholders (if applicable) and the transaction is consummated, the target business will have effectively
become public, whereas an initial public offering is always subject to the underwriters’ ability to complete the offering, as well
as general market conditions that could prevent the offering from occurring. Once public, we believe the target business would have greater
access to capital and additional means of creating management incentives that are better aligned with shareholders’ interests than
it would as a private company. It can offer further benefits by augmenting a company’s profile among potential new customers and
vendors and aid in attracting talented management staffs.
Strong Financial Position and Flexibility
With the funds held in our trust account, we can
offer a target business a variety of options to facilitate a business combination and fund future expansion and growth of its business.
Because we are able to consummate a business combination using the cash proceeds from this offering, our share capital, debt or a combination
of the foregoing, we have the flexibility to use an efficient structure allowing us to tailor the consideration to be paid to the target
business to address the needs of the parties. However, if a business combination requires us to use substantially all of our cash to pay
for the purchase price, we may need to arrange third party financing to help fund our business combination. Since we have no specific
business combination under consideration, we have not taken any steps to secure third party financing.
Acquisition Strategy
Our acquisition strategy will seek to capitalize
on M&A and operational expertise and relationship of both our management team and our board of directors, to identify attractive businesses
that have capacity to grow rapidly by utilizing a public vehicle. Although we are not limited to any particular industry, we intend to
primarily focus on companies operating in the Artificial Intelligence (“AI”) industry. There is no restriction in the geographic
location of targets that we can pursue, although we intend to initially prioritize geographic locations in North America, as our officers
and directors consist of successful entrepreneurs and senior executives with decades of operating and M&A experiences in the region.
AI has the potential to improve social productivity,
bring disruptive changes to people’s production and life including lower labor cost, better products and services, new markets and
more employment opportunities and is growing fully commercialized and bring profound changes to all industries. AI technologies have
been deployed in financial, healthcare, security and a number of other areas, with widening application scenarios. It is an industry above
all industries. Considering the growing impact of AI on social and economic development, US, Asia and European Union have released favorable
policies to include AI into national strategies.
Acquisition Criteria
The focus of our management team is to create
shareholder value by leveraging its experience to improve the efficiency of the business while implementing strategies to grow revenue
and profits organically and/or through acquisitions. Consistent with our strategy, we have identified the following general criteria and
guidelines that we believe are important in evaluating prospective target businesses. While we intend to use these criteria and guidelines
in evaluating prospective businesses, we may deviate from these criteria and guidelines should we see fit to do so:
We intend to acquire companies with
enterprise values of between $150 million and $300 million that are preferably already cash-generative. We believe we have greater access
to companies within this range and the negotiation process is generally less time consuming than companies that are much larger.
|
●
|
Long-term Revenue Visibility with Defensible Market Position
|
We intend to seek target companies that
are at an inflection point, such as those requiring additional management expertise, are able to innovate by developing new products or
services, or where we believe we can drive improved financial performance and where an acquisition may help facilitate growth.
|
●
|
Benefits from Being a U.S. Public Company (Value Creation and Marketing Opportunities)
|
We intend to seek target companies that
should offer attractive risk-adjusted equity returns for our shareholders. We intend to seek to acquire a target on terms and in a manner
that leverages our experience. We expect to evaluate financial returns based on (i) the potential for organic growth in cash flows, (ii)
the ability to achieve cost savings, (iii) the ability to accelerate growth, including through the opportunity for follow-on acquisitions
and (iv) the prospects for creating value through other value creation initiatives. Potential upside from growth in the target business’
earnings and an improved capital structure will be weighed against any identified downside risks.
These criteria are not intended to be exhaustive.
Any evaluation relating to the merits of a particular initial business combination may be based, to the extent relevant, on these general
guidelines as well as other considerations, factors and criteria that our management may deem relevant.
Competitive Weaknesses
We believe our competitive weaknesses to be the
following:
Limited Financial Resources
Our financial reserves will be relatively limited
when contrasted with those of venture capital firms, leveraged buyout firms and operating businesses competing for acquisitions. In addition,
our financial resources could be reduced because of our obligation to convert shares held by our public shareholders as well as any tender
offer we conduct.
Lack of experience with blank check companies
Our management team is not experienced in pursuing
business combinations on behalf of blank check companies. Other blank check companies may be sponsored and managed by individuals with
prior experience in completing business combinations between blank check companies and target businesses. Our managements’ lack
of experience may not be viewed favorably by target businesses.
Limited technical and human resources
As a blank check company, we have limited technical
and human resources. Many venture capital funds, leveraged buyout firms and operating businesses possess greater technical and human resources
than we do and thus we may be at a disadvantage when competing with them for target businesses.
Delay associated with shareholder approval
or tender offer
We may be required to seek shareholder approval
of our initial business combination. If we are not required to obtain shareholder approval of an initial business combination, we will
allow our shareholders to sell their shares to us pursuant to a tender offer. Both seeking shareholder approval and conducting a tender
offer will delay the consummation of our initial business combination. Other companies competing with us for acquisition opportunities
may not be subject to similar requirement, or may be able to satisfy such requirements more quickly than we can. As a result, we may be
at a disadvantage in competing for these opportunities.
Effecting a Business Combination
General
We are not presently engaged in, and we will not
engage in, any substantive commercial business for an indefinite period of time following this offering. We intend to utilize cash derived
from the proceeds of this offering and the private placement of private units, our share capital, debt or a combination of these in effecting
a business combination. Although substantially all of the net proceeds of this offering and the private placement of private units are
intended to be applied generally toward effecting a business combination as described in this prospectus, the proceeds are not otherwise
being designated for any more specific purposes. Accordingly, investors in this offering are investing without first having an opportunity
to evaluate the specific merits or risks of any one or more business combinations. A business combination may involve the acquisition
of, or merger with, a company which does not need substantial additional capital but which desires to establish a public trading market
for its shares, while avoiding what it may deem to be adverse consequences of undertaking a public offering itself. These include time
delays, significant expense, loss of voting control and compliance with various U.S. Federal and state securities laws. In the alternative,
we may seek to consummate a business combination with a company that may be in its early stages of development or growth. While we may
seek to effect simultaneous business combinations with more than one target business, we will probably have the ability, as a result of
our limited resources, to effect only a single business combination.
We Have Not Identified a Target Business
To date, we have not selected any target business
on which to concentrate our search for a business combination. None of our officers, directors, initial shareholders and other affiliates
has engaged in discussions on our behalf with representatives of other companies regarding the possibility of a potential merger, share
exchange, asset acquisition or other similar business combination with us, nor have we, nor any of our agents or affiliates, been approached
by any candidates (or representatives of any candidates) with respect to a possible business combination with our company.
Subject to the limitations that a target business
have a fair market value of at least 80% of the balance in the trust account (excluding any deferred underwriting discounts and commissions
and taxes payable on the income earned on the trust account) at the time of the execution of a definitive agreement for our initial business
combination, as described below in more detail, we will have virtually unrestricted flexibility in identifying and selecting a prospective
acquisition candidate. We have not established any other specific attributes or criteria (financial or otherwise) for prospective target
businesses. Accordingly, there is no basis for investors in this offering to evaluate the possible merits or risks of the target business
with which we may ultimately complete a business combination. To the extent we effect a business combination with a company or an entity
in its early stage of development or growth, including entities without established records of sales or earnings, we may be affected by
numerous risks inherent in the business and operations of early stage or potential emerging growth companies. Although our management
will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we will properly ascertain or
assess all significant risk factors.
Sources of Target Businesses
We anticipate that target business candidates
will be brought to our attention from various unaffiliated sources, including investment bankers, venture capital funds, private equity
funds, leveraged buyout funds, management buyout funds and other members of the financial community. Target businesses may be brought
to our attention by such unaffiliated sources as a result of being solicited by us through calls or mailings which will not commence until
after the completion of this offering. These sources may also introduce us to target businesses they think we may be interested in on
an unsolicited basis, since many of these sources will have read this prospectus and know what types of businesses we are targeting. Our
officers and directors, as well as their respective affiliates, may also bring to our attention target business candidates that they become
aware of through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as attending
trade shows or conventions. While we do not presently anticipate engaging the services of professional firms or other individuals that
specialize in business acquisitions on any formal basis, we may engage these firms or other individuals in the future, in which event
we may pay a finder’s fee, consulting fee or other compensation to be determined in an arm’s length negotiation based on the
terms of the transaction. In no event, however, will any of our existing officers, directors, special advisors or initial shareholders,
or any entity with which they are affiliated, be paid any finder’s fee, consulting fee or other compensation prior to, or for any
services they render in order to effectuate, the consummation of a business combination (regardless of the type of transaction), except
that Yongsheng Liu, our Chief Executive Officer will receive HK$50,000 (or approximately US$6,427 based on an exchange rate of HK$7.78
to US$1.00 on August 23, 2021) per month for his services to us. If we decide to enter into a business combination with a target business
that is affiliated with our officers, directors or initial shareholders, we will do so only if we have obtained an opinion from an independent
investment banking firm that the business combination is fair to our unaffiliated shareholders from a financial point of view. However,
as of the date of this prospectus, there is no affiliated entity that we consider a business combination target.
Selection of a Target Business and Structuring
of a Business Combination
Subject to the limitations that a target business
have a fair market value of at least 80% of the balance in the trust account (excluding any deferred underwriting discounts and commissions
and taxes payable on the income earned on the trust account) at the time of the execution of a definitive agreement for our initial business
combination, as described below in more detail, our management will have virtually unrestricted flexibility in identifying and selecting
a prospective target business. We have not established any other specific attributes or criteria (financial or otherwise) for prospective
target businesses. In evaluating a prospective target business, our management may consider a variety of factors, including one or more
of the following:
|
●
|
financial condition and results of operation;
|
|
●
|
experience and skill of management and availability of additional personnel;
|
|
●
|
stage of development of its products, processes or services;
|
|
●
|
degree of current or potential market acceptance of the products, processes or services;
|
|
●
|
proprietary features and degree of intellectual property or other protection for its products, processes or services;
|
|
●
|
regulatory environment of the industry; and
|
|
●
|
costs associated with effecting the business combination.
|
We believe such factors will be important in evaluating
prospective target businesses, regardless of the location or industry in which such target business operates. However, this list is not
intended to be exhaustive. Furthermore, we may decide to enter into a business combination with a target business that does not meet these
criteria and guidelines.
Any evaluation relating to the merits of a particular
business combination will be based, to the extent relevant, on the above factors as well as other considerations deemed relevant by our
management in effecting a business combination consistent with our business objective. In evaluating a prospective target business, we
will conduct an extensive due diligence review which will encompass, among other things, meetings with incumbent management and inspection
of facilities, as well as review of financial and other information which is made available to us. This due diligence review will be conducted
either by our management or by unaffiliated third parties we may engage, although we have no current intention to engage any such third
parties.
The time and costs required to select and evaluate
a target business and to structure and complete the business combination cannot presently be ascertained with any degree of certainty.
Any costs incurred with respect to the identification and evaluation of a prospective target business with which a business combination
is not ultimately completed will result in a loss to us and reduce the amount of capital available to otherwise complete a business combination.
Fair Market Value of Target Business
Pursuant to Nasdaq listing rules, the target business
or businesses that we acquire must collectively have a fair market value equal to at least 80% of the balance of the funds in the trust
account (excluding any deferred underwriting discounts and commissions and taxes payable on the income earned on the trust account) at
the time of the execution of a definitive agreement for our initial business combination, although we may acquire a target business whose
fair market value significantly exceeds 80% of the trust account balance. We currently anticipate structuring a business combination to
acquire 100% of the equity interests or assets of the target business or businesses. We may, however, structure a business combination
where we merge directly with the target business or where we acquire less than 100% of such interests or assets of the target business
in order to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such
business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or
otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under
the Investment Company Act. Even if the post-transaction company owns or acquires 50% or more of the voting securities of the target,
our shareholders prior to the business combination may collectively own a minority interest in the post-transaction company, depending
on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction in which
we issue a substantial number of new shares in exchange for all of the outstanding capital of a target. In this case, we could acquire
a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new shares, our shareholders
immediately prior to our initial business combination could own less than a majority of our issued and outstanding shares subsequent to
our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses are owned or
acquired by the post-transaction company, only the portion of such business or businesses that is owned or acquired is what will be valued
for purposes of the 80% of net assets test, assuming that we obtain and maintain a listing for our securities on NASDAQ. In order to consummate
such an acquisition, we may issue a significant amount of our debt or equity securities to the sellers of such businesses and/or seek
to raise additional funds through a private offering of debt or equity securities. Since we have no specific business combination under
consideration, we have not entered into any such fund raising arrangement and have no current intention of doing so. The fair market value
of the target will be determined by our board of directors based upon one or more standards generally accepted by the financial community
(such as actual and potential sales, earnings, cash flow and/or book value). If our board is not able to independently determine that
the target business has a sufficient fair market value, we will obtain an opinion from an unaffiliated, independent investment banking
firm, or another independent entity that commonly renders valuation opinions on the type of target business we are seeking to acquire,
with respect to the satisfaction of such criteria. We will not be required to obtain an opinion from an independent investment banking
firm, or another independent entity that commonly renders valuation opinions on the type of target business we are seeking to acquire,
as to the fair market value if our board of directors independently determines that the target business complies with the 80% threshold.
We will not be required to comply with the 80%
fair market value requirement if we are delisted from NASDAQ. If Nasdaq delists our securities from trading on its exchange after this
offering, we would not be required to satisfy the fair market value requirement described above and could complete a business combination
with a target business having a fair market value substantially below 80% of the balance in the trust account.
Lack of Business Diversification
Our business combination must be with a target
business or businesses that collectively satisfy the minimum valuation standard at the time of such acquisition, as discussed above, although
this process may entail the simultaneous acquisitions of several operating businesses at the same time. Therefore, at least initially,
the prospects for our success may be entirely dependent upon the future performance of a single business. Unlike other entities which
may have the resources to complete several business combinations of entities operating in multiple industries or multiple areas of a single
industry, it is probable that we will not have the resources to diversify our operations or benefit from the possible spreading of risks
or offsetting of losses. By consummating a business combination with only a single entity, our lack of diversification may:
|
●
|
subject us to numerous economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to a business combination, and
|
|
●
|
result in our dependency upon the performance of a single operating business or the development or market acceptance of a single or limited number of products, processes or services.
|
If we determine to simultaneously acquire several
businesses and such businesses are owned by different sellers, we will need for each of such sellers to agree that our purchase of its
business is contingent on the simultaneous closings of the other acquisitions, which may make it more difficult for us, and delay our
ability, to complete the business combination. With multiple acquisitions, we could also face additional risks, including additional burdens
and costs with respect to possible multiple negotiations and due diligence investigations (if there are multiple sellers) and the additional
risks associated with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating
business.
Limited Ability to Evaluate the Target Business’
Management
Although we intend to scrutinize the management
of a prospective target business when evaluating the desirability of effecting a business combination, we cannot assure you that our assessment
of the target business’ management will prove to be correct. In addition, we cannot assure you that the future management will have
the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of our officers and directors,
if any, in the target business following a business combination cannot presently be stated with any certainty. While it is possible that
some of our key personnel will remain associated in senior management or advisory positions with us following a business combination,
it is unlikely that they will devote their full time efforts to our affairs subsequent to a business combination. Moreover, they would
only be able to remain with the company after the consummation of a business combination if they are able to negotiate employment or consulting
agreements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the
business combination and could provide for them to receive compensation in the form of cash payments and/or our securities for services
they would render to the company after the consummation of the business combination. While the personal and financial interests of our
key personnel may influence their motivation in identifying and selecting a target business, their ability to remain with the company
after the consummation of a business combination will not be the determining factor in our decision as to whether or not we will proceed
with any potential business combination. Additionally, our officers and directors may not have significant experience or knowledge relating
to the operations of the particular target business.
Following a business combination, we may seek
to recruit additional managers to supplement the incumbent management of the target business. We cannot assure you that we will have the
ability to recruit additional managers, or that any such additional managers we do recruit will have the requisite skills, knowledge or
experience necessary to enhance the incumbent management.
Shareholders May Not Have the Ability to Approve an Initial Business
Combination
In connection with any proposed business combination,
we will either (1) seek shareholder approval of our initial business combination at a meeting called for such purpose at which public
shareholders may seek to convert their public shares, regardless of whether they vote for or against the proposed business combination,
into their pro rata share of the aggregate amount then on deposit in the trust account (net of taxes payable) or (2)
provide our public shareholders with the opportunity to sell their public shares to us by means of a tender offer (and thereby avoid the
need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the
trust account (net of taxes payable), in each case subject to the limitations described herein. Notwithstanding the foregoing, our initial
shareholders have agreed, pursuant to written letter agreements with us, not to convert any public shares held by them into their pro
rata share of the aggregate amount then on deposit in the trust account. If we determine to engage in a tender offer, such tender
offer will be structured so that each shareholder may tender any or all of his, her or its public shares rather than some pro
rata portion of his, her or its shares. The decision as to whether we will seek shareholder approval of a proposed business combination
or will allow shareholders to sell their shares to us in a tender offer will be made by us based on a variety of factors such as the timing
of the transaction, or whether the terms of the transaction would otherwise require us to seek shareholder approval. If we so choose and
we are legally permitted to do so, we have the flexibility to avoid a shareholder vote and allow our shareholders to sell their shares
pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act which regulate issuer tender offers. In that case, we will file tender offer
documents with the SEC which will contain substantially the same financial and other information about the initial business combination
as is required under the SEC’s proxy rules. We will consummate our initial business combination only if we have net tangible assets
of at least $5,000,001 upon such consummation and, solely if we seek shareholder approval, a majority of the issued and outstanding ordinary
shares voted are voted in favor of the business combination.
We chose our net tangible asset threshold of $5,000,001
to ensure that we would avoid being subject to Rule 419 promulgated under the Securities Act. However, if we seek to consummate an initial
business combination with a target business that imposes any type of working capital closing condition or requires us to have a minimum
amount of funds available from the trust account upon consummation of such initial business combination, our net tangible asset threshold
may limit our ability to consummate such initial business combination (as we may be required to have a lesser number of shares converted
or sold to us) and may force us to seek third party financing which may not be available on terms acceptable to us or at all. As a result,
we may not be able to consummate such initial business combination and we may not be able to locate another suitable target within the
applicable time period, if at all. Public shareholders may therefore have to wait 12 months from the closing of this offering (or 21 months
if we have extended the period of time as described in this prospectus) in order to be able to receive a pro rata share
of the trust account.
Our initial shareholders and our officers and
directors have agreed (1) to vote any ordinary shares owned by them in favor of any proposed business combination, (2) not to convert
any ordinary shares in connection with a shareholder vote to approve a proposed initial business combination and (3) not sell any ordinary
shares in any tender in connection with a proposed initial business combination. As a result, if we sought shareholder approval of a proposed
transaction we could need as little as 56,251 of our public shares (or approximately 1.12% of our public shares) to be voted in favor
of the transaction in order to have such transaction approved (assuming the over-allotment option is not exercised and the initial shareholders
do not purchase any units in this offering or units or shares in the after-market).
None of our officers, directors, initial shareholders
or their affiliates has indicated any intention to purchase units or ordinary shares in this offering or from persons in the open market
or in private transactions (other than the private units). However, if we hold a meeting to approve a proposed business combination and
a significant number of shareholders vote, or indicate an intention to vote, against such proposed business combination, our officers,
directors, initial shareholders or their affiliates could make such purchases in the open market or in private transactions in order to
influence the vote. Notwithstanding the foregoing, our officers, directors, initial shareholders and their affiliates will not make purchases
of ordinary shares if the purchases would violate Section 9(a)(2) or Rule 10b-5 of the Exchange Act, which are rules designed to stop
potential manipulation of a company’s stock.
Ability to Extend Time to Complete Business
Combination
If we anticipate that we may not be able to consummate
our initial business combination within 12 months, we may, but are not obligated to, extend the period of time to consummate a business
combination three times by an additional three months each time (for a total of up to 21 months to complete a business combination). Pursuant
to the terms of our amended and restated memorandum and articles of association and the trust agreement to be entered into between us
and Continental Stock Transfer & Trust Company, LLC on the date of this prospectus, in order to extend the time available for us to
consummate our initial business combination, our insiders or their affiliates or designees, upon five days advance notice prior to the
applicable deadline, must deposit into the trust account for each three month extension $500,000, or $575,000 if the underwriters’
over-allotment option is exercised in full ($0.10 per share in either case), on or prior to the date of the applicable deadline. The insiders
will receive a non-interest bearing, unsecured promissory note equal to the amount of any such deposit that will not be repaid in the
event that we are unable to close a business combination unless there are funds available outside the trust account to do so. Such notes
would either be paid upon consummation of our initial business combination, or, at the lender’s discretion, converted upon consummation
of our business combination into additional private units at a price of $10.00 per unit. Our shareholders have approved the issuance of
the private units upon conversion of such notes, to the extent the holder wishes to so convert such notes at the time of the consummation
of our initial business combination. In the event that we receive notice from our insiders five days prior to the applicable deadline
of their intent to effect an extension, we intend to issue a press release announcing such intention at least three days prior to the
applicable deadline. In addition, we intend to issue a press release the day after the applicable deadline announcing whether or not the
funds had been timely deposited. Our insiders and their affiliates or designees are not obligated to fund the trust account to extend
the time for us to complete our initial business combination. To the extent that some, but not all, of our insiders, decide to extend
the period of time to consummate our initial business combination, such insiders (or their affiliates or designees) may deposit the entire
amount required. Any notes issued pursuant to these loans would be in addition to any notes issued pursuant to working capital loans made
to us.
Conversion/Tender Rights
At any meeting called to approve an initial business
combination, public shareholders may seek to convert their public shares, regardless of whether they vote for or against the proposed
business combination, into their pro rata share of the aggregate amount then on deposit in the trust account, less any
taxes then due but not yet paid. Notwithstanding the foregoing, our initial shareholders have agreed, pursuant to written letter agreements
with us, not to convert any public shares held by them into their pro rata share of the aggregate amount then on deposit
in the trust account. The conversion rights will be effected under our amended and restated memorandum and articles of association and
British Virgin Islands law as redemptions. If we hold a meeting to approve an initial business combination, a holder will always have
the ability to vote against a proposed business combination and not seek conversion of his shares.
Alternatively, if we engage in a tender offer,
each public shareholder will be provided the opportunity to sell his public shares to us in such tender offer. The tender offer rules
require us to hold the tender offer open for at least 20 business days. Accordingly, this is the minimum amount of time we would need
to provide holders to determine whether they want to sell their public shares to us in the tender offer or remain an investor in our company.
Our initial shareholders, officers and directors
will not have conversion rights with respect to any ordinary shares owned by them, directly or indirectly, whether acquired prior to this
offering or purchased by them in this offering or in the aftermarket.
We may also require public shareholders, whether
they are a record holder or hold their shares in “street name,” to either tender their certificates (if any) to our transfer
agent or to deliver their shares to the transfer agent electronically using Depository Trust Company’s DWAC (Deposit/Withdrawal
At Custodian) System, at the holder’s option, at any time at or prior to the vote on the business combination. Once the shares are
converted by the holder, and effectively redeemed by us under British Virgin Islands law, the transfer agent will then update our Register
of Members to reflect all conversions. The proxy solicitation materials that we will furnish to shareholders in connection with the vote
for any proposed business combination will indicate whether we are requiring shareholders to satisfy such delivery requirements. Accordingly,
a shareholder would have from the time our proxy statement is mailed through the vote on the business combination to deliver his shares
if he wishes to seek to exercise his conversion rights. Under our amended and restated memorandum and articles of association, we are
required to provide at least 10 days’ advance notice of any shareholder meeting, which would be the minimum amount of time a shareholder
would have to determine whether to exercise conversion rights. As a result, if we require public shareholders who wish to convert their
ordinary shares into the right to receive a pro rata portion of the funds in the trust account to comply with the foregoing
delivery requirements, holders may not have sufficient time to receive the notice and deliver their shares for conversion. Accordingly,
investors may not be able to exercise their conversion rights and may be forced to retain our securities when they otherwise would not
want to.
There is a nominal cost associated with this tendering
process and the act of certificating the shares or delivering them through the DWAC System. The transfer agent will typically charge the
tendering broker $45 and it would be up to the broker whether or not to pass this cost on to the converting holder. However, this fee
would be incurred regardless of whether or not we require holders seeking to exercise conversion rights. The need to deliver shares is
a requirement of exercising conversion rights regardless of the timing of when such delivery must be effectuated. However, in the event
we require shareholders seeking to exercise conversion rights to deliver their shares prior to the consummation of the proposed business
combination and the proposed business combination is not consummated, this may result in an increased cost to shareholders.
Any request to convert or tender such shares once
made, may be withdrawn at any time up to the vote on the proposed business combination or expiration of the tender offer. Furthermore,
if a holder of a public share delivered his certificate in connection with an election of their conversion or tender and subsequently
decides prior to the vote on the business combination or the expiration of the tender offer not to elect to exercise such rights, he may
simply request that the transfer agent return the certificate (physically or electronically).
If the initial business combination is not approved
or completed for any reason, then our public shareholders who elected to exercise their conversion or tender rights would not be entitled
to convert their shares for the applicable pro rata share of the trust account. In such case, we will promptly return
any shares delivered by public holders.
Automatic Liquidation of Trust Account if No Business Combination
If we do not complete a business combination within
12 months (or 21 months, if we extend the time to complete a business combination as described in this prospectus) from the consummation
of this offering, it will trigger our automatic winding up, liquidation and subsequent dissolution pursuant to the terms of our amended
and restated memorandum and articles of association. As a result, this has the same effect as if we had formally gone through a voluntary
liquidation procedure under the Companies Law. Accordingly, no vote would be required from our shareholders to commence such a voluntary
winding up, liquidation and subsequent dissolution. However, if we anticipate that we may not be able to consummate our initial business
combination within 12 months, we may, but are not obligated to, extend the period of time to consummate a business combination three times
by an additional three months each time (for a total of up to 21 months to complete a business combination). Pursuant to the terms of
our amended and restated memorandum and articles of association and the trust agreement to be entered into between us and Continental
Stock Transfer & Trust Company, LLC on the date of this prospectus, in order to extend the time available for us to consummate our
initial business combination, our insiders or their affiliates or designees, upon five days advance notice prior to the applicable deadline,
must deposit into the trust account for each three month extension $500,000, or $575,000 if the underwriters’ over-allotment option
is exercised in full ($0.10 per share in either case), on or prior to the date of the applicable deadline. The insiders will receive a
non-interest bearing, unsecured promissory note equal to the amount of any such deposit that will not be repaid in the event that we are
unable to close a business combination unless there are funds available outside the trust account to do so. Such notes would either be
paid upon consummation of our initial business combination, or, at the lender’s discretion, converted upon consummation of our business
combination into additional private units at a price of $10.00 per unit. Our shareholders have approved the issuance of the private units
upon conversion of such notes, to the extent the holder wishes to so convert such notes at the time of the consummation of our initial
business combination. In the event that we receive notice from our insiders five days prior to the applicable deadline of their intent
to effect an extension, we intend to issue a press release announcing such intention at least three days prior to the applicable deadline.
In addition, we intend to issue a press release the day after the applicable deadline announcing whether or not the funds had been timely
deposited. Our insiders and their affiliates or designees are not obligated to fund the trust account to extend the time for us to complete
our initial business combination. To the extent that some, but not all, of our insiders, decide to extend the period of time to consummate
our initial business combination, such insiders (or their affiliates or designees) may deposit the entire amount required. If we are unable
to consummate our initial business combination within such time period, we will, as promptly as possible but not more than ten business
days thereafter, redeem 100% of our outstanding public shares for a pro rata portion of the funds held in the trust account, including
a pro rata portion of any interest earned on the funds held in the trust account and not necessary to pay our taxes, then seek to liquidate
and dissolve. However, we may not be able to distribute such amounts as a result of claims of creditors which may take priority over the
claims of our public shareholders. In the event of our liquidation and subsequent dissolution, the public rights will expire and will
be worthless.
The amount in the trust account under the Companies
Law will be treated as funds distributable under the Companies Law provided that immediately following the date on which the proposed
distribution is proposed to be made, we are able to pay our debts as they fall due in the ordinary course of business. If we are forced
to liquidate the trust account, we anticipate that we would distribute to our public shareholders the amount in the trust account calculated
as of the date that is two days prior to the distribution date (including any accrued interest). Prior to such distribution, we would
be required to assess all claims that may be potentially brought against us by our creditors for amounts they are actually owed and make
provision for such amounts, as creditors take priority over our public shareholders with respect to amounts that are owed to them. We
cannot assure you that we will properly assess all claims that may be potentially brought against us. As such, our shareholders could
potentially be liable for any claims of creditors to the extent of distributions received by them as an unlawful payment in the event
we enter an insolvent liquidation. Furthermore, while we will seek to have all vendors and service providers (which would include any
third parties we engaged to assist us in any way in connection with our search for a target business) and prospective target businesses
execute agreements with us waiving any right, title, interest or claim of any kind they may have in or to any monies held in the trust
account, there is no guarantee that they will execute such agreements. Nor is there any guarantee that, even if such entities execute
such agreements with us, they will not seek recourse against the trust account or that a court would conclude that such agreements are
legally enforceable.
Each of our initial shareholders and our
officers and directors have agreed to waive its rights to participate in any liquidation of our trust account or other assets with
respect to the insider shares and private units and to vote their insider shares, private shares in favor of any liquidation and
plan of distribution which we submit to a vote of shareholders. There will be no distribution from the trust account with respect to
our warrants or rights, which will expire worthless.
If we are unable to complete an initial business combination and expend all of
the net proceeds of this offering, other than the proceeds deposited in the trust account, and without taking into account interest,
if any, earned on the trust account, the initial per-share distribution from the trust account would be $10.00.
The proceeds deposited in the trust account could,
however, become subject to the claims of our creditors which would be prior to the claims of our public shareholders. Although we will
seek to have all vendors, including lenders for money borrowed, prospective target businesses or other entities we engage execute agreements
with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public
shareholders, there is no guarantee that they will execute such agreements or even if they execute such agreements that they would be
prevented from bringing claims against the trust account, including but not limited to, fraudulent inducement, breach of fiduciary responsibility
or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with
a claim against our assets, including the funds held in the trust account. If any third party refused to execute an agreement waiving
such claims to the monies held in the trust account, we would perform an analysis of the alternatives available to us if we chose not
to engage such third party and evaluate if such engagement would be in the best interest of our shareholders if such third party refused
to waive such claims. Examples of possible instances where we may engage a third party that refused to execute a waiver include the engagement
of a third party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other
consultants that would agree to execute a waiver or in cases where management is unable to find a provider of required services willing
to provide the waiver. In any event, our management would perform an analysis of the alternatives available to it and would only enter
into an agreement with a third party that did not execute a waiver if management believed that such third party’s engagement would
be significantly more beneficial to us than any alternative. In addition, there is no guarantee that such entities will agree to waive
any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not
seek recourse against the trust account for any reason.
Cross Wealth Investment Holding Limited, which
is owned by our director, Jining Li, has agreed that, if we liquidate the trust account prior to the consummation of a business combination,
it will be liable to pay debts and obligations to target businesses or vendors or other entities that are owed money by us for services
rendered or contracted for or products sold to us in excess of the net proceeds of this offering not held in the trust account, but only
to the extent necessary to ensure that such debts or obligations do not reduce the amounts in the trust account and only if such parties
have not executed a waiver agreement. However, we cannot assure you that he will be able to satisfy those obligations if he is required
to do so. Accordingly, the actual per-share distribution could be less than $10.00 due to claims of creditors.
Competition
In identifying, evaluating and selecting a target
business, we may encounter intense competition from other entities having a business objective similar to ours. Many of these entities
are well established and have extensive experience identifying and effecting business combinations directly or through affiliates. Many
of these competitors possess greater technical, human and other resources than us and our financial resources will be relatively limited
when contrasted with those of many of these competitors. While we believe there may be numerous potential target businesses that we could
acquire with the net proceeds of this offering, our ability to compete in acquiring certain sizable target businesses may be limited by
our available financial resources.
The following also may not be viewed favorably
by certain target businesses:
|
●
|
our
obligation to seek shareholder approval of a business combination or obtain the necessary financial information to be sent to shareholders
in connection with such business combination may delay or prevent the completion of a transaction;
|
|
●
|
our
obligation to convert public shares held by our public shareholders may reduce the resources available to us for a business combination;
|
|
●
|
Nasdaq
may require us to file a new listing application and meet its initial listing requirements to maintain the listing of our securities
following a business combination;
|
|
●
|
our
outstanding warrants, rights and unit purchase options and the potential future dilution they represent;
|
|
●
|
our
obligation to pay the deferred underwriting discounts and commissions to Maxim Group LLC upon consummation of our initial business combination;
|
|
●
|
our
obligation to either repay or issue units upon conversion of up to $500,000 of working capital loans that may be made to us by our initial
shareholders, officers, directors or their affiliates;
|
|
●
|
our
obligation to register the resale of the insider shares, as well as the private units (and underlying securities) and any securities
issued to our initial shareholders, officers, directors or their affiliates upon conversion of working capital loans; and
|
|
●
|
the
impact on the target business’ assets as a result of unknown liabilities under the securities laws or otherwise depending on developments
involving us prior to the consummation of a business combination.
|
Any of these factors may place us at a competitive
disadvantage in successfully negotiating a business combination. Our management believes, however, that our status as a public entity
and potential access to the United States public equity markets may give us a competitive advantage over privately-held entities having
a similar business objective as ours in acquiring a target business with significant growth potential on favorable terms.
If we succeed in effecting a business combination,
there will be, in all likelihood, intense competition from competitors of the target business. We cannot assure you that, subsequent to
a business combination, we will have the resources or ability to compete effectively.
Facilities
We maintain our principal executive office at
15/F, Aubin House, 171-172 Gloucester Road, Wanchai, Hong Kong. The cost for this space is provided to us by Golden Bridge Capital Limited,
which is also owned by Mr. Jining Li, the Company’s director and also the affiliate of the sponsor, as part of the $10,000 per month
payment we make to it for office space and related services. We consider our current office space adequate for our current operations.
Employees
We have three executive officers, one of whom,
Yongsheng Liu, our Chief Executive Officer, is also an employee. These individuals are not obligated to devote any specific number of
hours to our matters and intend to devote only as much time as they deem necessary to our affairs. The amount of time they will devote
in any time period will vary based on whether a target business has been selected for the business combination and the stage of the business
combination process the company is in. Accordingly, once management locates a suitable target business to acquire, they will spend more
time investigating such target business and negotiating and processing the business combination (and consequently spend more time to our
affairs) than they would prior to locating a suitable target business. We presently expect our executive officers to devote such amount
of time as they reasonably believe is necessary to our business (which could range from only a few hours a week while we are trying to
locate a potential target business to a majority of their time as we move into serious negotiations with a target business for a business
combination). We do not intend to have any full time employees prior to the consummation of a business combination.
ITEM
1A. RISK FACTORS
Our ordinary shares subject to redemption
are classified for as outside permanent equity and the changes in classification could have a material effect on our financial results.
In addition, in preparation of the Company’s
financial statements as of and for the year ended June 30, 2021, the Company concluded it should revise its financial statements to classify
all ordinary shares subject to possible redemption in temporary equity. In accordance with the SEC and its staff’s guidance on redeemable
equity instruments, ASC Topic 480, Distinguishing Liabilities from Equity (ASC 480), paragraph 10-S99, redemption provisions not solely
within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. The Company
had previously classified a portion of its ordinary shares in permanent equity. Although the Company did not specify a maximum redemption
threshold, its charter provides that currently, the Company will not redeem its public shares in an amount that would cause its net tangible
assets to be less than $5,000,001. The Company considered that the threshold would not change the nature of the underlying shares as redeemable
and thus would be required to be disclosed outside equity. As a result, the Company revised its previously filed financial statements
to classify all ordinary shares as temporary equity and to recognize accretion from the initial book value to redemption value at the
time of its Initial Public Offering and in accordance with ASC 480. The change in the carrying value of redeemable shares of ordinary
shares resulted in charges against accumulated deficit.
We have identified a material weakness in
our internal control over financial reporting as of June 30, 2021. If we are unable to develop and maintain an effective system of internal
control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely
affect investor confidence in us and materially and adversely affect our business and operating results.
Following the issuance of the SEC Statement, our
management and our audit committee concluded that, in light of the SEC Statement, it was appropriate to restate our previously issued
audited financial statements as of and for the year ended June 30, 2021. See “—the changes on classification of permanent
equity could have a material effect on our financial results.” As part of such process, we identified a material weakness in our
internal controls over financial reporting.
A material weakness is a deficiency, or a combination of deficiencies,
in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or
interim financial statements will not be prevented, or detected and corrected on a timely basis. Effective internal controls are necessary
for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate the material weakness. These
remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended
effects
ITEM
1B. UNRESOLVED STAFF COMMENTS
Not applicable.
ITEM
2. PROPERTIES
We do not own any real estate or other physical
properties materially important to our operations. We maintain our principal executive offices at 15/F, Aubin House, 171-172 Gloucester
Road, Wanchai, Hong Kong. The cost for this space is provided to us by Golden Bridge Capital Limited, which is also owned by Mr. Jining
Li, the Company’s director and also the affiliate of the sponsor, as part of the $10,000 per month payment we make to it for office
space and related services. We consider our current office space adequate for our current operations.
ITEM
3. LEGAL PROCEEDINGS
We may be subject to legal proceedings, investigations
and claims incidental to the conduct of our business from time to time. We are not currently a party to any material litigation or other
legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that
has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.
ITEM
4. MINE SAFETY DISCLOSURES
Not Applicable.
PART III
ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Our current directors and executive officers are as follows:
Name
|
|
Age
|
|
Position
|
Yongsheng Liu
|
|
51
|
|
Director, Chief Executive Officer, and Chairman
|
Yanhong Xue
|
|
48
|
|
Chief Financial Officer
|
Ray Chen
|
|
55
|
|
Chief Operating Officer
|
Jining Li
|
|
63
|
|
Director
|
Kinpui Choi
|
|
66
|
|
Independent Director
|
Michael Chen
|
|
58
|
|
Independent Director
|
Claude P. Franco
|
|
57
|
|
Independent Director
|
Below is a summary of the business experience
of each our executive officers and directors:
Yongsheng Liu. Mr. Liu has been
our Chief Executive Officer and Chairman of our Board since August 2020. Throughout the past 20 years, Mr. Liu has assumed various corporate
leadership positions and demonstrated his strong execution ability and in-depth knowledge in private equity and corporate M&A transactions
across a wide range of sectors including aviation, consumer, financial institutions, and technology. He served as the chairman and chief
executive officer of Wealthbridge Acquisition Limited, a special purpose acquisition company, from June 2018 until its business combination
with Scienjoy Inc. in May 2020, and currently serves as the vice chairman of Scienjoy’s board since then. From March 2017 to April
2018, Mr. Liu served as chairman and chief executive officer of Royal China Holdings Limited (HKEx: 01683), during which he spearheaded
the company’s international growth strategy focused at acquiring targets in aviation industry and finance sector. From the beginning
of 2013 to March 2017, Mr. Liu was the chairman of Joy Air General Aviation, chairman of Cambodia Bayon Airlines, vice chairman of Everbright
and Joy International Leasing Company, and president of General Aviation Investment Company (Shanghai). From April 2004 to August 2008,
Mr. Liu also served as chief strategy officer of United Eagle Airlines (subsequently renamed to Chengdu Airlines). From December 1994
to June 2000, Mr. Liu was a manager of China Southern Airlines responsible for ground staff training. Mr. Liu received his master degree
from University of Ottawa in 2002 and his bachelor’s degree from Civil Aviation Univeristy of China in 1992. We believe Mr. Liu
is well-qualified to serve as a member of our board of directors given his experience, relationships and contacts.
Ray Chen. Mr. Chen has been our
Chief Operating Officer since August 2020. Mr. Chen served as the director and chief operating officer of Wealthbridge Acquisition Limited,
a special purpose acquisition company, from February 2018 until its business combination with Scienjoy Inc. in May 2020, and currently
serves as the investor relation officer of Scienjoy since then. Mr. Chen served as chief executive officer at Fortissimo Film International
Ltd., a privately-owned film development and production company from August 2016 till January 2018. From January 2013 to February 2016,
Mr. Chen was the chief executive officer of Beijing Galloping Horse Film & TV Production Co., Ltd. From January 2010 to March 2013,
Mr. Chen was the head of sales in the Beijing Office of Star Jet Co., Ltd. Prior to his Star Jet experience, Mr. Chen was the executive
board member and head of sales in Asia Jet Partners Limited, a privately-owned holding company specializing in general aviation and aircraft
leasing. Mr. Chen joined Asia Jet after his service as chief executive officer at ABC International Inc., a business consulting company
based in Cleveland, Ohio. Mr. Chen holds a graduate certificate in Marketing from Cleveland State University.
Yanhong Xue. Ms. Xue has been our
Chief Financial Officer since August 2020. She is currently serving as a chief financial officer at BIMI International Medical Inc.. since
July 2021. Since 2011, Ms. Xue has been a partner of Wall Street CPA Services, LLC, where she provides chief financial officer services
and accounting services to Ifresh Inc., XT Energy Group Inc. and several other U.S. public companies, coordinating investors, investment
bankers, directors and legal counsels for corporate finance issues, and performing investor relations duties, including networking with
investors, presenting and discussing operating results on investor conferences. Ms. Xue worked as a senior manager at Acquavella, Chiarelli,
Shuster, Berkower & Co., LLP from September 2007 to October 2010 where she focused on SEC auditing services. She also worked at China
Youth Daily as a finance and accounting manager from September 1997 to October 2004. Ms. Xue received her bachelor degree in history and
law from Peking University in 1997 and master degree in accounting from State University of New York at Binghamton in 2007.
Jining Li. Mr. Li has served as
a Director of our Board since August 2020. Mr. Li served as the director of Wealthbridge Acquisition Limited, a special purpose acquisition
company, from June 2018 until its business combination with Scienjoy Inc. in May 2020. Mr. Li is the founder and has acted as the chairman
of Star Jet Co., Ltd in Shanghai, China, since May 2011. He also serves as director of Keen Nice Communications Limited since November
2017, HK Karsing Investment Limited since April 2008, and Star Jet (Hong Kong) Limited, since March 2012. Prior to Star Jet, Mr. Li founded
United Eagle Airlines as the first non-government-owned airline company in the history of Chinese aviation industry in 2004. From 2004
to 2008, Mr. Li was the chairman of United Eagle Airlines. He served as the chairman of China Internet Investment Finance Holdings Limited
(HKEx: 00810) from 2005 to 2007. In 1998, Mr. Li founded Guangdong Ying Lian Tong Telecommunication Services Co., Ltd and served as Chairman
until 2004. From 1990 to 1998, Mr. Li served as chairman of Huahui Import and Export Trading Company. From 1988 to 1990, Mr. Li served
as a manager in Guangdong Branch of China Council for the Promotion of International Trade. We believe Mr. Li is well-qualified to
serve as a member of our board of directors given his experience, relationships and contacts.
Kinpui Choi. Mr. Choi has served
as a Director since August 2020. Mr. Choi served as the director of Wealthbridge Acquisition Limited, a special purpose acquisition company,
from September 2018 until its business combination with Scienjoy Inc. in May 2020. He has over 26 years of senior management experience
in telecommunication industry in Hong Kong, U.S. and China. From 2002 to 2006, he was the president and chief executive officer of Elephant
Talk Communications Inc. Mr. Choi founded Elephant Talk Limited in 1994, a wholly-owned subsidiary of Elephant Talk Communications Inc.
From April 1994 to August 2002, Mr. Choi was the chief executive officer of Elephant Talk Limited. From January 2013 to September 2018,
Mr. Choi served as the independent director of Universal Success Group Limited (HKEx:00487). Previously, he also served as the chairman
of ET Network Services Limited (later known as Guangdong Ming Ying Financial Leasing Co Limited), a Hong Kong-based company which specializes
in providing telecommunication services in China. We believe Mr. Choi is well-qualified to serve as a member of our board of directors
given his experience, relationships and contacts.
Michael Chen. Mr. Chen has served
as a Director since August 2020. Since February 2009, Mr. Chen is currently the general partner and chief executive officer of Chen &
Associates, an advisory services firm focused on the financial services, media, aviation, and food industries. Mr. Chen co-founded the
firm in 1997 and joined full-time in 2013. He also serves as the vice chairman of Grace Farms Foundation (www.gracefarms.org) and as the
chairman of The CEO Forum Group (www.theceoforumgroup.com). From 2012-2013, Mr. Chen was a management committee advisor and strategic
partner to the chief investment officer at Bridgewater Associates. From 2011-2012, he was the president of NBC News’ Strategic Initiatives
Group and served on the board of directors for The Weather Channel. Prior to joining NBC News, he served as the president and chief executive
officer of GE Capital’s media, communications, and entertainment business from 2006-2010. He was also the chairman of the board
and creator of the Peacock Equity Fund from 2006-2010, which was a digital media fund supported by GE and NBC Universal and later was
sold to Comcast in 2011. Mr. Chen started as a financial analyst at IBM in 1985. After spending nine years at IBM in various financial
and management positions, he joined GE in 1994 as vice president of risk and portfolio management for GE Capital Aviation Services (“GECAS”),
where he was responsible for underwriting and evaluating airline financing deals for North America. He was appointed as senior vice president
and general manager, North America of GECAS in 1999. Mr. Chen currently serves as an Emeritus Advisory Council member for the SC Johnson
School of Business at Cornell University. In addition, he previously served on the board of The Weather Channel, the Norwalk Community
College Foundation, the Diversity Advisory Board at Sodexo Corporation, the Executive Diversity Council of GE, and the Planning Team for
Grace Community Church. He was named the top Asian American in business in 2008 by the Asian American Business Development Center, and
he was presented with the “Distinguished Service Award” by Norwalk Community College in 2010. Mr. Chen received his bachelor’s
degree in electrical engineering from the University of Rochester and an MBA degree in finance from the SC Johnson School of Business
at Cornell University. We believe Mr. Chen is well-qualified to serve as a member of our board of directors given his experience, relationships
and contacts.
Claude P. Franco. Mr. Franco has
served as a Director since August 2020. Mr. Franco is a skilled aircraft and engine leasing executive with airline restructuring and aircraft
manufacturing experience. He previously served as a founder of Global Jet Capital, a company that provides leasing/financing solutions
to the global private aircraft industry. This company was taken over by the Carlyle Group in 2015. Over the past 25 plus years he has
worked at United Technologies Corporation focusing on sikorsky aircraft helicopter design, GECAS where he was responsible for commercial
aircraft and commercial engine leasing and airline restructuring worldwide, Gulfstream Aerospace, Guggenheim Partners and White Oak Global
Advisors. Mr. Franco’s experience in commercial aircraft leasing and finance, credit analysis, aviation parts (aftermarket and new)
and asset management provide him a strong ability to assess existing or start-up leasing businesses. He also has securitized and bought
and sold portfolios of aircraft and engines held by leasing companies and airlines. Mr. Franco knows and has relationships with many of
the large leasing companies worldwide, aviation parts companies as well as global airlines and aircraft and engine manufacturers. He has
strong experience managing through downturns, for example SARS, MERS, 9-11, and COVID-19 pandemic and understands the impact they had
(are having) on leases, asset values and parts companies. Mr. Franco has spent a good portion of his career in front of prospective investors
explaining aviation opportunities and downturn situations. He has a keen ability to read his audience, understand their concerns and address
the risks and mitigants of the aviation leasing and aftermarket businesses. He relies on these credit skills to make potential investors
comfortable and successfully negotiate debt lines with lenders. He has experience in negotiating transactions globally and also has experience
with US and foreign governments. Mr. Franco has a solid understanding of manufacturing (operational process, contracts, sales, progress
payments, etc.) and has negotiated transactions from most all major aircraft manufacturers worldwide. Mr. Franco has held securities and
exchange licenses (Series 7 and 63), and has an understanding of the laws of securities and fixed income products. He holds degrees in
aeronautical studies with engineering and management focus from Embry-Riddle Aeronautical University and an MBA degree from Emory University.
We believe Mr. Franco is well-qualified to serve as a member of our board of directors given his experience, relationships and contacts.
Director Independence
Nasdaq requires that a majority of our board must
be composed of “independent directors.” Currently, Kinpui Choi, Michael Chen and Claude P. Franco would each be considered
an “independent director” under the Nasdaq listing rules, which is defined generally as a person other than an officer or
employee of the company or its subsidiaries or any other individual having a relationship, which, in the opinion of the company’s
board of directors would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of
a director. Our independent directors will have regularly scheduled meetings at which only independent directors are present.
We will only enter into a business combination
if it is approved by a majority of our independent directors. Additionally, we will only enter into transactions with our officers and
directors and their respective affiliates that are on terms no less favorable to us than could be obtained from independent parties. Any
related-party transactions must also be approved by our audit committee and a majority of disinterested independent directors.
Board Committees
The Board has a standing audit, nominating and
compensation committee, which were established at the closing of our initial public offering. The independent directors oversee director
nominations. Each committee has a charter, which was filed with the SEC as exhibits to the Registration Statement on Form S-1 on February
22, 2021.
Audit Committee
The Audit Committee, which is established in accordance
with Section 3(a)(58)(A) of the Exchange Act, engages Company’s independent accountants, reviewing their independence and performance;
reviews the Company’s accounting and financial reporting processes and the integrity of its financial statements; the audits of
the Company’s financial statements and the appointment, compensation, qualifications, independence and performance of the Company’s
independent auditors; the Company’s compliance with legal and regulatory requirements; and the performance of the Company’s
internal audit function and internal control over financial reporting. The Audit Committee held one meeting during 2021.
The members of the Audit Committee are Kinpui
Choi, Michael Chen, and Claude P. Franco, each of whom is an independent director under NASDAQ’s listing standards. Kinpui Choi
is the Chairperson of the audit committee. The Board has determined that both Kinpui Choi qualify as an “audit committee financial
expert,” as defined under the rules and regulations of the SEC.
Nominating Committee
The Nominating Committee is responsible for overseeing
the selection of persons to be nominated to serve on our Board. Specifically, the Nominating Committee makes recommendations to the Board
regarding the size and composition of the Board, establishes procedures for the director nomination process and screens and recommends
candidates for election to the Board. On an annual basis, the Nominating Committee recommends for approval by the Board certain desired
qualifications and characteristics for board membership. Additionally, the Nominating Committee establishes and administers a periodic
assessment procedure relating to the performance of the Board as a whole and its individual members. The Nominating Committee will consider
a number of qualifications relating to management and leadership experience, background and integrity and professionalism in evaluating
a person’s candidacy for membership on the Board. The Nominating Committee may require certain skills or attributes, such as financial
or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and
makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not distinguish among nominees
recommended by shareholders and other persons. The Nominating Committee held one meeting during 2021.
The members of the Nominating Committee are Kinpui
Choi, Michael Chen, and Claude P. Franco, each of whom is an independent director under NASDAQ’s listing standards. Kinpui Choi
is the Chairperson of the Nominating Committee.
Compensation Committee
The Compensation Committee reviews annually the
Company’s corporate goals and objectives relevant to the officers’ compensation, evaluates the officers’ performance
in light of such goals and objectives, determines and approves the officers’ compensation level based on this evaluation; makes
recommendations to the Board regarding approval, disapproval, modification, or termination of existing or proposed employee benefit plans,
makes recommendations to the Board with respect to non-CEO and non-CFO compensation and administers the Company’s incentive-compensation
plans and equity-based plans. The Compensation Committee has the authority to delegate any of its responsibilities to subcommittees as
it may deem appropriate in its sole discretion. The chief executive officer of the Company may not be present during voting or deliberations
of the Compensation Committee with respect to his compensation. The Company’s executive officers do not play a role in suggesting
their own salaries. Neither the Company nor the Compensation Committee has engaged any compensation consultant who has a role in determining
or recommending the amount or form of executive or director compensation. The Compensation Committee held no meetings during 2021.
Notwithstanding the foregoing, as indicated above,
no compensation of any kind, including finders, consulting or other similar fees, will be paid to any of our existing shareholders, including
our directors, or any of their respective affiliates, prior to, or for any services they render in order to effectuate, the consummation
of a business combination. Accordingly, it is likely that prior to the consummation of an initial business combination, the compensation
committee will only be responsible for the review and recommendation of any compensation arrangements to be entered into in connection
with such initial business combination.
The members of the Compensation Committee are
Kinpui Choi, Michael Chen, and Claude P. Franco, each of whom is an independent director under NASDAQ’s listing standards. Kinpui
Choi is the Chairperson of the Compensation Committee.
Conflicts of Interest
Investors should be aware of the following potential
conflicts of interest:
|
●
|
None
of our officers and directors is required to commit their full time to our affairs and, accordingly, they may have conflicts of interest
in allocating their time among various business activities.
|
|
●
|
In
the course of their other business activities, our officers and directors may become aware of investment and business opportunities which
may be appropriate for presentation to our company as well as the other entities with which they are affiliated. Our management has pre-existing
fiduciary duties and contractual obligations and may have conflicts of interest in determining to which entity a particular business
opportunity should be presented.
|
|
●
|
Our
officers and directors may in the future become affiliated with entities, including other blank check companies, engaged in business
activities similar to those intended to be conducted by our company.
|
|
●
|
The
insider shares owned by our officers and directors will be released from escrow only if a business combination is successfully completed
and subject to certain other limitations. Additionally, our officers and directors will not receive distributions from the trust account
with respect to any of their insider shares if we do not complete a business combination. In addition, our officers and directors may
loan funds to us after the IPO and may be owed reimbursement for expenses incurred in connection with certain activities on our behalf
which would only be repaid if we complete an initial business combination. For the foregoing reasons, the personal and financial interests
of our directors and executive officers may influence their motivation in identifying and selecting a target business, completing a business
combination in a timely manner and securing the release of their shares.
|
Under British Virgin Islands law, directors owe
the following fiduciary duties:
|
●
|
duty
to act in good faith in what the director believes to be in the best interests of the company as a whole;
|
|
●
|
duty
to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;
|
|
●
|
directors
should not properly fetter the exercise of future discretion;
|
|
●
|
duty
not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and
|
|
●
|
duty
to exercise independent judgment.
|
In addition to the above, directors also owe a
duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having
both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried
out by that director in relation to the company and the general knowledge skill and experience which that director has.
As set out above, directors have a duty not to
put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of
their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance
by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the memorandum
and articles of association or alternatively by shareholder approval at general meetings.
Accordingly, as a result of multiple business
affiliations, our officers and directors may have similar legal obligations relating to presenting business opportunities meeting the
above-listed criteria to multiple entities. In addition, conflicts of interest may arise when our board evaluates a particular business
opportunity with respect to the above-listed criteria. We cannot assure you that any of the above mentioned conflicts will be resolved
in our favor. Furthermore, most of our officers and directors have pre-existing fiduciary obligations to other businesses of which they
are officers or directors. To the extent they identify business opportunities which may be suitable for the entities to which they owe
pre-existing fiduciary obligations, our officers and directors will honor those fiduciary obligations. Accordingly, it is possible they
may not present opportunities to us that otherwise may be attractive to us unless the entities to which they owe pre-existing fiduciary
obligations and any successors to such entities have declined to accept such opportunities.
In order to minimize potential conflicts of interest
which may arise from multiple corporate affiliations, each of our officers and directors has contractually agreed, pursuant to a written
agreement with us, until the earliest of a business combination, our liquidation or such time as he ceases to be an officer or director,
to present to our company for our consideration, prior to presentation to any other entity, any suitable business opportunity which may
reasonably be required to be presented to us, subject to any pre-existing fiduciary or contractual obligations he might have.
The following table summarizes the current pre-existing
fiduciary or contractual obligations of our officers and directors.
Name of Individual
|
|
Name of Affiliated Company
|
|
Affiliation
|
|
Priority/Preference relative
to Goldenbridge
Acquisition Limited
|
Jining Li
|
|
Star Jet Co., Ltd.
|
|
Founder and Chairman
|
|
Star Jet Co., Ltd.
|
Michael Chen
|
|
Chen & Associates
|
|
General Partner and
Chief Executive Officer
|
|
Chen & Associates
|
Yanhong Xue
|
|
Wall Street CPA Services, LLC
|
|
Partner
|
|
Wall Street CPA Services, LLC
|
In connection with the vote required for any business
combination, all of our existing shareholders, including all of our officers and directors, have agreed to vote their respective insider
shares and private shares in favor of any proposed business combination. In addition, they have agreed to waive their respective rights
to participate in any liquidation distribution with respect to those ordinary shares acquired by them prior to the IPO. If they purchased
ordinary shares in the IPO or in the open market, however, they would be entitled to participate in any liquidation distribution in respect
of such shares but have agreed not to convert such shares (or sell their shares in any tender offer) in connection with the consummation
of our initial business combination or an amendment to our amended and restated memorandum and articles of association relating to pre-business
combination activity.
All ongoing and future transactions between us
and any of our officers and directors or their respective affiliates will be on terms believed by us to be no less favorable to us than
are available from unaffiliated third parties. Such transactions will require prior approval by our audit committee and a majority of
our uninterested “independent” directors, or the members of our board who do not have an interest in the transaction, in either
case who had access, at our expense, to our attorneys or independent legal counsel. We will not enter into any such transaction unless
our audit committee and a majority of our disinterested “independent” directors determine that the terms of such transaction
are no less favorable to us than those that would be available to us with respect to such a transaction from unaffiliated third parties.
To further minimize conflicts of interest, we
have agreed not to consummate our initial business combination with an entity that is affiliated with any of our officers, directors or
initial shareholders, unless we have obtained (i) an opinion from an independent investment banking firm that the business combination
is fair to our unaffiliated shareholders from a financial point of view and (ii) the approval of a majority of our disinterested and independent
directors (if we have any at that time). Furthermore, in no event will any of our initial shareholders, officers, directors, special advisors
or their respective affiliates be paid any finder’s fee, consulting fee or other similar compensation prior to, or for any services
they render in order to effectuate, the consummation of our initial business combination.
Code of Ethics
We adopted a code of conduct and ethics applicable
to our directors, officers and employees in accordance with applicable federal securities laws. The code of ethics codifies the business
and ethical principles that govern all aspects of our business.
Section 16(a) Beneficial Ownership Reporting
Compliance
Section 16(a) of the Securities Exchange Act of
1934, as amended, or the Exchange Act, requires our executive officers, directors and persons who beneficially own more than 10% of a
registered class of our equity securities to file with the Securities and Exchange Commission initial reports of ownership and reports
of changes in ownership of our ordinary shares and other equity securities. These executive officers, directors, and greater than 10%
beneficial owners are required by SEC regulation to furnish us with copies of all Section 16(a) forms filed by such reporting persons.
Based solely on our review of such forms furnished
to us and written representations from certain reporting persons, we believe that all filing requirements applicable to our executive
officers, directors and greater than 10% beneficial owners were filed in a timely manner.
ITEM
11. EXECUTIVE COMPENSATION
Employment Agreements
We have not entered into any employment agreements
with our executive officers, and have not made any agreements to provide benefits upon termination of employment.
Executive
Officer and Director Compensation
Other
than the $10,000 per month administrative fee paid to Golden Bridge Capital Limited, which is also owned by Mr. Jining Li, the Company’s
director and also the affiliate of the sponsor, and HK$50,000 (or approximately US$6,451 based on an exchange rate of HK$7.75 to US$1.00
on January 12, 2021) per month has been paid since June, 2020 to Yongsheng Liu, our Chief Executive Officer, for his services to us,
no compensation of any kind, including finders, consulting or other similar fees, has been paid or will be paid to any of our existing
shareholders, including our directors, or any of their respective affiliates, prior to, or for any services they render in order to effectuate,
the consummation of a business combination. However, such individuals will be reimbursed for any out-of-pocket expenses incurred in connection
with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.
There is no limit on the amount of these out-of-pocket expenses and there will be no review of the reasonableness of the expenses by
anyone other than our board of directors and audit committee, which includes persons who may seek reimbursement, or a court of competent
jurisdiction if such reimbursement is challenged.
After
the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting,
management or other fees from the combined company. All the these fees will be fully disclosed to shareholders, to the extent then known,
in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination.
It is unlikely the amount of such compensation will be known at the time, because the directors of the post-combination business will
be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will
be determined by a compensation committee constituted solely of independent directors.
We
do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation
of our initial business combination, although it is possible that some or all of our executive officers and directors may negotiate employment
or consulting arrangements to remain with us after the initial business combination. The existence or terms of any such employment or
consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting
a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business
combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any
agreements with our executive officers and directors that provide for benefits upon termination of employment.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
The
following table sets forth as of August 23, 2021 the number of ordinary shares beneficially owned by (i) each person who is known by
us to be the beneficial owner of more than five percent of our issued and outstanding ordinary shares (ii) each of our officers and directors;
and (iii) all of our officers and directors as a group. As of August 23, 2021, we had 7,566,250 ordinary shares issued and outstanding.
Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary
shares beneficially owned by them. The following table does not reflect record of beneficial ownership of any ordinary shares issuable
upon exercise of the warrants or conversion of rights, as the warrants are not exercisable within 60 days of August 23, 2021 and
the rights are not convertible within 60 days of August 23, 2021.
Name and Address of Beneficial Owner(1)
|
|
Amount and Nature of
Beneficial Ownership of
Ordinary Shares
|
|
|
Approximate Percentage of Outstanding Shares of
Ordinary Shares
|
|
Cross Wealth Investment Holding Limited(2)
|
|
|
470,583
|
|
|
|
6.22
|
%
|
Yongsheng Liu(3)
|
|
|
245,250
|
|
|
|
3.24
|
%
|
Yanhong Xue
|
|
|
15,000
|
|
|
|
*
|
|
Ray Chen
|
|
|
15,000
|
|
|
|
*
|
|
Jining Li (2)
|
|
|
470,583
|
|
|
|
6.22
|
%
|
Kinpui Choi
|
|
|
15,000
|
|
|
|
*
|
|
Michael Chen(4)
|
|
|
15,000
|
|
|
|
*
|
|
Claude P. Franco
|
|
|
15,000
|
|
|
|
*
|
|
Golden Bridge Holding, LLC
|
|
|
300,000
|
|
|
|
3.96
|
%
|
Scienjoy Inc.(5)
|
|
|
606,061
|
|
|
|
8.01
|
%
|
Lucky Link International Limited
|
|
|
30,000
|
|
|
|
*
|
|
Can Wu
|
|
|
60,606
|
|
|
|
*
|
|
Boothbay Fund Management, LLC(6)
|
|
|
333,317
|
|
|
|
4.41
|
%
|
Ari Glass(6)
|
|
|
333,317
|
|
|
|
4.41
|
%
|
Space Summit Capital LLC(7)
|
|
|
300,000
|
|
|
|
3.96
|
%
|
All directors and officers as a group (7 individuals)
|
|
|
790,833
|
|
|
|
10.45
|
%
|
(1)
|
Unless otherwise
indicated, the business address of each of the individuals is c/o Goldenbridge Acquisition Limited, 15/F, Aubin House, 171-172 Gloucester
Road, Wanchai, Hong Kong.
|
(2)
|
Mr. Jining
Li owns and controls Cross Wealth Investment Holding Limited, our sponsor.
|
(3)
|
Mr. Yongsheng
Liu owns and controls such shares through Asia Pacific Capital Management Limited.
|
(4)
|
Mr. Michael
Chen owns and controls such shares through Chen & Associates, LLC.
|
(5)
|
Based on a
Schedule 13G filed by the reporting persons. The address for the reporting persons is the 3rd Floor, Jia No. 34, Shenggu Nanli, Chaoyang
District, Beijing, F4 100029. Scienjoy Inc. is a wholly owned subsidiary of Scienjoy Holding Corporation. Scienjoy Holding Corporation
may be deemed to beneficially own 606,061 Ordinary Shares held by Scienjoy Inc.
|
(6)
|
Based on a
Schedule 13G filed by the reporting persons. The address for the reporting persons is 140 East 45th Street, 14th Floor, New York,
NY 10017. Boothbay Fund Management, LLC, a Delaware limited liability company (the “Adviser”), in its capacity as the
investment manager of the Fund, has the power to vote and the power to direct the disposition of all Units held by the Fund. Ari
Glass is the Managing Member of the Adviser. Shares reported may be deemed beneficially owned by Boothbay Fund Management, LLC and
Ari Glass.
|
(7)
|
Based on a
Schedule 13G filed by the reporting person. The address for the reporting persons is 15455 Albright Street, Pacific Palisades, CA
90272. Space Summit Capital LLC, a Delaware limited liability company, may be deemed as the beneficial owner of 300,000 Ordinary
Shares,.
|
All
of the insider shares issued and outstanding prior to the IPO were placed in escrow with Continental Stock Transfer & Trust Company,
LLC, as escrow agent, until (1) with respect to 50% of the insider shares, the earlier of one year after the date of the consummation
of our initial business combination and the date on which the closing price of our ordinary shares equals or exceeds $12.50 per share
(as adjusted for share splits, share capitalizations, reorganizations and recapitalizations) for any 20 trading days within any 30-trading
day period commencing after our initial business combination and (2) with respect to the remaining 50% of the insider shares, one year
after the date of the consummation of our initial business combination, or earlier, in either case, if, subsequent to our initial business
combination, we consummate a liquidation, merger, share exchange or other similar transaction which results in all of our shareholders
having the right to exchange their shares for cash, securities or other property.
During
the escrow period, the holders of these shares will not be able to sell or transfer their securities except (i) to the Company’s
pre-IPO shareholders, or to the Company’s officers, directors, advisors and employees, (ii) if the Initial Shareholder is an entity,
as a distribution to partners, members or shareholders of the Initial Shareholder upon the liquidation and dissolution of the Initial
Shareholder, (iii) by bona fide gift to a member of the Initial Shareholder’s immediate family or to a trust, the beneficiary of
which is the Initial Shareholder or a member of the Initial Shareholder’s immediate family for estate planning purposes, (iv) by
virtue of the laws of descent and distribution upon death of the Initial Shareholder, (v) pursuant to a qualified domestic relations
order, (vi) by private sales made in connection with the consummation of a Business Combination at prices no greater than the price at
which the Private Units were originally purchased or (vii) to the Company for cancellation in connection with the consummation of our
initial business combination, in each case (except for clause (vii)) where the transferee agrees to the terms of the escrow agreement,
but will retain all other rights as our shareholders, including, without limitation, the right to vote their ordinary shares and the
right to receive cash dividends, if declared. If dividends are declared and payable in ordinary shares, such dividends will also be placed
in escrow. If we are unable to effect a business combination and liquidate the trust account, none of our initial shareholders will receive
any portion of the liquidation proceeds with respect to their insider shares.
In
order to meet our working capital needs, our initial shareholders, officers and directors or their affiliates may, but are not obligated
to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would
be evidenced by a promissory note. The notes would either be paid upon consummation of our initial business combination, without interest,
or, at the lender’s discretion, up to $500,000 of the notes may be converted upon consummation of our business combination into
private units at a price of $10.00 per unit (which, for example, would result in the holders being issued units to acquire 55,000 ordinary
shares (which includes 5,000 shares issuable upon conversion of rights) and warrants to purchase 25,000 ordinary shares if $500,000 of
notes were so converted). Our shareholders have approved the issuance of the units and underlying securities upon conversion of such
notes, to the extent the holder wishes to so convert them at the time of the consummation of our initial business combination. If we
do not complete a business combination, the loans will not be repaid.
Our
Sponsor and our executive officers and directors are deemed to be our “promoters,” as that term is defined under the Federal
securities laws.
ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
In
August 2019, 10,000 shares were sold. In September 2020, the Company issued another 1,427,500 ordinary shares resulting in an aggregate
of 1,437,500 ordinary shares outstanding to the sponsor and our directors and officers, which we refer to throughout this prospectus
as the “insider shares,” for an aggregate purchase price of $25,000, or approximately $0.017 per share. In January 2021,
our sponsor transferred part of its insider shares to Golden Bridge Holding, LLC, Scienjoy Inc., Lucky Link International Limited, and
Can Wu, and after such transfers, our sponsor currently owns 120,583 ordinary shares.
Simultaneously
with the closing of the IPO, the Company consummated the private placement with certain of its initial shareholders of 350,000 units
at a price of $10.00 per Private Unit, generating total proceeds of $3,500,000.
In
order to meet our working capital needs following the consummation of the IPO, our initial shareholders, officers and directors and their
respective affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of our
initial business combination, without interest, or, at the lender’s discretion, up to $500,000 of the notes may be converted upon
consummation of our business combination into private units at a price of $10.00 per unit (which, for example, would result in the holders
being issued units to acquire 55,000 ordinary shares (which includes 5,000 shares issuable upon conversion of rights) and warrants to
purchase 25,000 ordinary shares if $500,000 of notes were so converted). Our shareholders have approved the issuance of the units and
underlying securities upon conversion of such notes, to the extent the holder wishes to so convert them at the time of the consummation
of our initial business combination. If we do not complete a business combination, the loans would be repaid out of funds not held in
the trust account, and only to the extent available.
The
holders of our insider shares issued and outstanding prior to the date of the IPO, as well as the holders of the private units (and all
underlying securities) and any securities our initial shareholders, officers, directors or their affiliates may be issued in payment
of working capital loans made to us, will be entitled to registration rights pursuant to offering registration rights agreement. The
holders of a majority of these securities are entitled to make up to two demands that we register such securities. The holders of the
majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date
on which these ordinary shares are to be released from escrow. The holders of a majority of the private units or securities issued in
payment of working capital loans made to us can elect to exercise these registration rights at any time after we consummate a business
combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements
filed subsequent to our consummation of a business combination. We will bear the expenses incurred in connection with the filing of any
such registration statements.
We
will reimburse our officers and directors for any reasonable out-of-pocket business expenses incurred by them in connection with certain
activities on our behalf such as identifying and investigating possible target businesses and business combinations. There is no limit
on the amount of out-of-pocket expenses reimbursable by us; provided, however, that to the extent such expenses exceed the available
proceeds not deposited in the trust account and the interest income earned on the amounts held in the trust account, such expenses would
not be reimbursed by us unless we consummate an initial business combination. Our audit committee will review and approve all reimbursements
and payments made to any initial shareholder or member of our management team, or our or their respective affiliates, and any reimbursements
and payments made to members of our audit committee will be reviewed and approved by our Board of Directors, with any interested director
abstaining from such review and approval.
Other
than the $10,000 per month administrative fee paid to Golden Bridge Capital Limited, which is also owned by Mr. Jining Li, the Company’s
director and also the affiliate of the sponsor, and HK$50,000 (or approximately US$6,427 based on an exchange rate of HK$7.78 to US$1.00
on August 23, 2021) per month has been paid since June, 2020 to Yongsheng Liu, our Chief Executive Officer, for his services to us, no
compensation of any kind, including finders, consulting or other similar fees, has been paid or will be paid to any of our existing shareholders,
including our directors, or any of their respective affiliates, prior to, or for any services they render in order to effectuate, the
consummation of a business combination. However, such individuals will be reimbursed for any out-of-pocket expenses incurred in connection
with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.
There is no limit on the amount of these out-of-pocket expenses and there will be no review of the reasonableness of the expenses by
anyone other than our board of directors and audit committee, which includes persons who may seek reimbursement, or a court of competent
jurisdiction if such reimbursement is challenged.
All
ongoing and future transactions between us and any of our officers and directors or their respective affiliates will be on terms believed
by us to be no less favorable to us than are available from unaffiliated third parties. Such transactions, including the payment of any
compensation, will require prior approval by a majority of our uninterested “independent” directors (to the extent we have
any) or the members of our board who do not have an interest in the transaction, in either case who had access, at our expense, to our
attorneys or independent legal counsel. We will not enter into any such transaction unless our disinterested “independent”
directors (or, if there are no “independent” directors, our disinterested directors) determine that the terms of such transaction
are no less favorable to us than those that would be available to us with respect to such a transaction from unaffiliated third parties.
Related
Party Policy
Our
Code of Ethics requires us to avoid, wherever possible, all related party transactions that could result in actual or potential conflicts
of interests, except under guidelines approved by the board of directors (or the audit committee). Related-party transactions are defined
as transactions in which (1) the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year, (2) we or
any of our subsidiaries is a participant, and (3) any (a) executive officer, director or nominee for election as a director, (b) greater
than 5% beneficial owner of our ordinary shares, or (c) immediate family member, of the persons referred to in clauses (a) and (b), has
or will have a direct or indirect material interest (other than solely as a result of being a director or a less than 10% beneficial
owner of another entity). A conflict of interest situation can arise when a person takes actions or has interests that may make it difficult
to perform his or her work objectively and effectively. Conflicts of interest may also arise if a person, or a member of his or her family,
receives improper personal benefits as a result of his or her position.
We
also require each of our directors and executive officers to annually complete a directors’ and officers’ questionnaire that
elicits information about related party transactions.
Our
audit committee, pursuant to its written charter, will be responsible for reviewing and approving related-party transactions to the extent
we enter into such transactions. All ongoing and future transactions between us and any of our officers and directors or their respective
affiliates will be on terms believed by us to be no less favorable to us than are available from unaffiliated third parties. Such transactions
will require prior approval by our audit committee and a majority of our uninterested “independent” directors, or the members
of our board who do not have an interest in the transaction, in either case who had access, at our expense, to our attorneys or independent
legal counsel. We will not enter into any such transaction unless our audit committee and a majority of our disinterested “independent”
directors determine that the terms of such transaction are no less favorable to us than those that would be available to us with respect
to such a transaction from unaffiliated third parties. Additionally, we require each of our directors and executive officers to complete
a directors’ and officers’ questionnaire that elicits information about related party transactions.
These
procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a
conflict of interest on the part of a director, employee or officer.
To
further minimize potential conflicts of interest, we have agreed not to consummate a business combination with an entity which is affiliated
with any of our initial shareholders unless we obtain an opinion from an independent investment banking firm that the business combination
is fair to our unaffiliated shareholders from a financial point of view. Furthermore, in no event will any of our existing officers,
directors or initial shareholders, or any entity with which they are affiliated, be paid any finder’s fee, consulting fee or other
compensation prior to, or for any services they render in order to effectuate, the consummation of a business combination.
Director
Independence
Nasdaq
listing standards require that within one year of the listing of our securities on the Nasdaq Capital Market we have at least three independent
directors and that a majority of our board of directors be independent. For a description of the director independence, see above Part
III, Item 10 - Directors, Executive Officers and Corporate Governance.
ITEM
14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The
following is a summary of fees paid or to be paid to Friedman LLP, or Friedman, for services rendered.
Audit
Fees. Audit fees consist of fees billed for professional services rendered for the audit of our year-end financial statements and
services that are normally provided by Friedman in connection with regulatory filings. The aggregate fees billed by Friedman for professional
services rendered for the audit of our annual financial statements, review of the financial information included in our Forms 10-Q for
the respective periods and other required filings with the SEC for the year ended June 30, 2021 and for the period from August 12, 2019
(inception) through June 30, 2020 totaled approximately $89,000 and $30,000, respectively. The above amounts include interim procedures
and audit fees, as well as attendance at audit committee meetings.
Audit-Related
Fees. Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance
of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include attest
services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards. We
did not pay Friedman for consultations concerning financial accounting and reporting standards for the year ended June 30, 2021 and for
the period from August 12, 2019 (inception) through June 30, 2020.
Tax
Fees. We did not pay Friedman for tax planning and tax advice for the year ended June 30, 2021 and for the period from August 12,
2019 (inception) through June 30, 2020.
All
Other Fees. We did not pay Friedman for other services for the year ended June 30, 2021 and for the period from August 12, 2019 (inception)
through June 30, 2020.
Pre-Approval
Policy
Our
audit committee was formed upon the consummation of our Initial Public Offering. As a result, the audit committee did not pre-approve
all of the foregoing services, although any services rendered prior to the formation of our audit committee were approved by our board
of directors. All services subsequent to the formation of the audit committee have been approved by the audit committee.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Currency
expressed in United States Dollars (“US$”), except for number of shares)
NOTE
1 – ORGANIZATION AND BUSINESS BACKGROUND
Goldenbridge
Acquisition Limited (“Goldenbridge”, the “Company” or “we”, “us” and “our”)
is a newly organized blank check company incorporated on August 12, 2019, under the laws of the British Virgin Islands for the purpose
of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all of the assets
of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses or entities
(Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating
a Business Combination, the Company intends to focus on opportunities in the artificial intelligence and any other related technology
innovations market in North America.
CVS
X Limited (“CVSX”) is a company incorporated on May 11, 2021, under the laws of the Cayman Island for the purpose of effecting
the Business Combination. CVSX is wholly owned by Goldenbridge.
Smart
CVS Limited (“SCL”, or together with CVSX, “the subsidiaries”) is a company incorporated on May 21, 2021, under
the laws of the Cayman Island for the purpose of effecting the Business Combination. SCL is wholly owned by CVSX.
AgiiPlus
Global Inc., (“PubCo”) is a company incorporated in the Cayman Islands for the purpose of effecting the Business Combination
and to serve as the vehicle for, and be subsumed by, AgiiPlus Inc., pursuant to the Acquisition Merger. PubCo is wholly owned by the
Goldenbridge.
AgiiPlus
Corporation Inc., (“Merger Sub”) is a company incorporated in the Cayman Islands for the purpose of effecting the Business
Combination and to serve as the vehicle for, and be subsumed by, AgiiPlus Inc., pursuant to the Acquisition Merger. Merger Sub is wholly
owned by the PubCo.
On
September 30, 2021, the Company entered into a definitive agreement or non-binding letter of intent to acquire a company, AgiiPlus Inc.,
(“AgiiPlus”). The aggregate consideration to be paid to AgiiPlus shareholders for the Acquisition Merger is $520 million,
payable in the form of a number of newly issued Purchaser Ordinary Shares (the “Closing Payment Shares”) valued at the $10.00
per share. Under the Merger Agreement, 1,000,000 shares of the Closing Payment Shares (“Escrow Shares”) to be issued will
be held in escrow for a period of 6 months after the closing to satisfy indemnification obligations.
As
of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation
and the Public Offering as described below. The Company has selected June 30 as its fiscal year end.
Financing
The
registration statement for the Company’s initial public offering (the “Public Offering” as described in Note 4) was
declared effective by the United States Securities and Exchange Commission (“SEC”) on March 1, 2021. The Company consummated
the Public Offering on March 4, 2021 of 5,000,000 units at $10.00 per unit (the “Public Units’). Subsequently, on March 9,
2021, the underwriters exercised the option in full of 750,000 units at a price of $10.00 per unit. Concurrently with the Public Offering,
the Company sold to Cross Wealth Investment Holding Limited (the “Sponsor”) 350,000 private units at a price of $10.00 per
unit and sold to Maxim Group LLC for $100 an option to purchase 287,500 units at an exercise price of $11.50 per unit. The Company received
net proceeds of approximately $59,162,906 (which includes deferred underwriting commissions of $2,012,500). Transaction costs amounted
to $1,837,194, consisting of $1,437,500 of underwriter’s fees and $399,694 of other offering costs.
Trust
Account
Upon
the closing of the Public Offering and the private placement, $57,500,000 was placed in a trust account (the “Trust Account”)
with Continental Stock Transfer & Trust Company, LLC acting as trustee. The funds held in the Trust Account can be invested in United
States government treasury bills, bonds or notes, having a maturity of 180 days or less or in money market funds meeting certain conditions
under Rule 2a-7 promulgated under the Investment Company Act until the earlier of (i) the consummation of the Company’s initial
business combination within the required time period and (ii) the redemption of 100% of the outstanding public shares if the Company
has not completed an initial business combination in the required time period. Placing funds in the Trust Account may not protect those
funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective
target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies
held in the Trust Account, there is no guarantee that such persons will execute such agreements. The remaining net proceeds (not held
in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing
general and administrative expenses. Additionally, the interest earned on the Trust Account balance may be released to the Company to
pay the Company’s tax obligations.
Business
Combination
Pursuant
to Nasdaq listing rules, the Company’s initial business combination must occur with one or more target businesses having an aggregate
fair market value equal to at least 80% of the value of the funds in the Trust Account (excluding any deferred underwriter’s fees
and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution
of a definitive agreement for our initial business combination, although the Company may structure a business combination with one or
more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed
on Nasdaq, it will not be required to satisfy the 80% test. The Company currently anticipates structuring a business combination to acquire
100% of the equity interests or assets of the target business or businesses.
GOLDENBRIDGE
ACQUISITION LIMITED
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Currency
expressed in United States Dollars (“US$”), except for number of shares)
The
Company may, however, structure a business combination where the Company merges directly with the target business or where the Company
acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management
team or shareholders or for other reasons, but the Company will only complete such business combination if the post-transaction company
owns 50% or more of the outstanding voting securities of the target or otherwise owns a controlling interest in the target sufficient
for it not to be required to register as an investment company under the Investment Company Act. If less than 100% of the equity interests
or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses
that is owned or acquired is what will be valued for purposes of the 80% test.
The
Company will either seek shareholder approval of any business combination at a meeting called for such purpose at which shareholders
may seek to convert their shares into their pro rata share of the aggregate amount then on deposit in the Trust Account, less any taxes
then due but not yet paid, or provide shareholders with the opportunity to sell their shares to the Company by means of a tender offer
for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, less any taxes then due but
not yet paid. These shares have been recorded at redemption value and are classified as temporary equity, in accordance with Financial
Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing
Liabilities from Equity .” The Company will proceed with a business combination only if it will have net tangible assets of
at least $5,000,001 upon consummation of the business combination and, solely if shareholder approval is sought, a majority of the outstanding
ordinary shares of the Company voted are voted in favor of the business combination.
In
connection with any shareholder vote required to approve any business combination, the Initial Shareholders have agreed (i) to vote any
of their respective shares, including the ordinary shares sold to the Initial Shareholders in connection with the organization of the
Company, ordinary shares included in the Private Units sold in the Private Placement, and any ordinary shares which were initially issued
in connection with the Public Offering, whether acquired in or after the effective date of the IPO, in favor of the initial business
combination and (ii) not to convert such respective shares into a pro rata portion of the Trust Account or seek to sell their shares
in connection with any tender offer the Company engages in.
Liquidation
If
the Company does not complete a business combination within 12 months from the consummation of the Public Offering, it will trigger an
automatic winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum and articles of association.
As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies
Law. Accordingly, no vote would be required from the Company’s shareholders to commence such a voluntary winding up, dissolution
and liquidation. However, if the Company anticipates that the Company may not be able to consummate its initial business combination
within 12 months, the Company may, but is not obligated to, extend the period of time to consummate a business combination three times
by an additional three months each time (for a total of up to 21 months to complete a business combination). Pursuant to the terms of
the amended and restated memorandum and articles of association and the trust agreement entered into between the Company and Continental
Stock Transfer & Trust Company, LLC on the effective date of the Registration Statement, in order to extend the time available for
the Company to consummate the initial business combination, the Company’s insiders or their affiliates or designees, upon five
days advance notice prior to the applicable deadline, must deposit into the trust account $575,000 ($0.10 per share), on or prior to
the date of the applicable deadline. The insiders will receive a non-interest bearing, unsecured promissory note equal to the amount
of any such deposit that will not be repaid in the event that the Company is unable to close a business combination unless there are
funds available outside the trust account to do so. Such notes would either be paid upon consummation of the Company’s initial
business combination, or, at the lender’s discretion, converted upon consummation of the business combination into additional private
units at a price of $10.00 per unit. The Company’s shareholders have approved the issuance of the private units upon conversion
of such notes, to the extent the holder wishes to so convert such notes at the time of the consummation of the Company’s initial
business combination. In the event that the Company receives notice from the Company’s insiders five days prior to the applicable
deadline of their intent to effect an extension, the Company intends to issue a press release announcing such intention at least three
days prior to the applicable deadline. In addition, the Company intends to issue a press release the day after the applicable deadline
announcing whether or not the funds had been timely deposited. The Company’s insiders and their affiliates or designees are not
obligated to fund the trust account to extend the time for the Company to complete the initial business combination. To the extent that
some, but not all, of the Company’s insiders, decide to extend the period of time to consummate the Company initial business combination,
such insiders (or their affiliates or designees) may deposit the entire amount required. If the Company is unable to consummate the Company’s
initial business combination within such time period, the Company will, as promptly as possible but not more than ten business days thereafter,
redeem 100% of the Company’s outstanding public shares for a pro rata portion of the funds held in the trust account, including
a pro rata portion of any interest earned on the funds held in the trust account and not necessary to pay taxes, and then seek to liquidate
and dissolve. However, the Company may not be able to distribute such amounts as a result of claims of creditors which may take priority
over the claims of the Company’s public shareholders. In the event of dissolution and liquidation, the public rights will expire
and will be worthless.
GOLDENBRIDGE
ACQUISITION LIMITED
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
(Currency
expressed in United States Dollars (“US$”), except for number of shares)
NOTE
2 – SIGNIFICANT ACCOUNTING POLICIES
These
accompanying consolidated financial statements have been prepared in U.S. Dollars in conformity with generally accepted accounting principles
in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of
the Securities and Exchange Commission (the “SEC”). In the opinion of management, all adjustments (consisting of normal recurring
adjustments) have been made that are necessary to present fairly the consolidated financial position, and the results of its consolidated
operations and its consolidated cash flows.
●
|
Principles of consolidation
|
The
consolidated financial statements include the financial statements of the Company and its subsidiaries. All significant intercompany
transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.
Subsidiaries
are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to
govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a
majority of votes at the meeting of directors.
The
accompanying consolidated financial statements reflect the activities of the Company and each of the following entities:
Name
|
|
Background
|
|
Ownership
|
CVS X Limited (“CVSX”)
|
|
A Cayman Island company Incorporated on May 11, 2021
|
|
100% Owned by Goldenbridge
|
|
|
|
|
|
Smart CVS Limited (“SCL”)
|
|
A Cayman Island company Incorporated on May 21, 2021
|
|
100% Owned by CVSX
|
●
|
Emerging growth company
|
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously
approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.
In
preparing these consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements and the reported expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, Actual results may
differ from these estimates.
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
●
|
Cash and cash equivalents
|
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of June 30, 2021 or 2020.
●
|
Cash and investments held in trust account
|
At June 30, 2021 and 2020, the assets held in
the Trust Account are held in cash and US Treasury securities. Investment securities in the Company’s Trust Account consisted of
$57,496,825 in United States Treasury Bills and $2,326 in cash.
The Company classified investments that are directly
invested in U.S. Treasuries as available for sales and money market funds are classified in accordance with the trading method. All marketable
securities are recorded at their estimated fair value. Unrealized gains and losses for available-for-sale securities are recorded in other
comprehensive income (loss). The Company evaluates its investments to assess whether those with unrealized loss positions are other than
temporarily impaired. Impairments are considered other than temporary if they are related to deterioration in credit risk or if it is
likely the Company will sell the securities before the recovery of the cost basis. Realized gains and losses and declines in value determined
to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net
in the statements of operations and comprehensive income (loss).
The Company accounts for warrants as either equity-classified
or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance
in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing
Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC 815”). The
assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability
pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether
the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net
cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This
assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly
period end date while the warrants are outstanding.
For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance.
For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded
as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair
value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The initial fair value of the Private
Warrants was estimated using a Black-Scholes model (see Note 9).
●
|
Ordinary shares subject to possible redemption
|
The Company accounts for its ordinary shares
subject to possible redemption in accordance with the guidance in ASC Topic 480 Distinguishing Liabilities from Equity. Ordinary shares
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity.
At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain
redemption rights that are subject to occurrence of uncertain future events and considered to be outside of the Company’s control.
Accordingly, at June 30, 2021 and 2020, 5,750,000 and 1,437,500 ordinary shares subject to possible redemption, respectively, are presented
as temporary equity, outside of the shareholders’ equity section of the Company’s condensed consolidated balance sheets.
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
The Company complies with the requirements of
the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of Offering”.
Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the
Public Offering and that were charged to shareholders’ equity upon the completion of the Public Offering.
●
|
Fair value of financial instruments
|
ASC Topic 820 “Fair Value Measurements
and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the
buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach,
income approach and cost approach shall be used to measure fair value. ASC Topic 820 establishes a fair value hierarchy for inputs, which
represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable
and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market
data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that
the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.
The fair value hierarchy is categorized into three
levels based on the inputs as follows:
Level 1 —
|
Valuations based on unadjusted quoted
prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block
discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market,
valuation of these securities does not entail a significant degree of judgment.
|
Level 2 —
|
Valuations based on (i) quoted prices
in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets,
(iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated
by market through correlation or other means.
|
Level 3 —
|
Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
|
The fair value of the Company’s certain
assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,”
approximates the carrying amounts represented in the balance sheet. The fair values of cash and cash equivalents, and other current assets,
accrued expenses, due to sponsor are estimated to approximate the carrying values as of June 30, 2021 due to the short maturities of such
instruments. See Note 9 for the disclosure of the Company’s assets and liabilities that were measured at fair value on a recurring
basis.
●
|
Concentration of credit risk
|
Financial instruments that potentially subject
the Company to concentration of credit risk consist of cash and trust accounts in a financial institution which, at times may exceed
the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes
the Company is not exposed to significant risks on such accounts.
The Company complies with the accounting and reporting
requirements of ASC Topic 740, “ Income Taxes ,” which requires an asset and liability approach to financial accounting
and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the consolidated financial
statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws
and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.
GOLDENBRIDGE ACQUISITION LIMITED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
ASC Topic 740 prescribes a recognition threshold
and a measurement attribute for the consolidated financial statement recognition and measurement of tax positions taken or expected to
be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s major tax jurisdiction.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were
no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021. The Company is currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company calculates net loss per share in accordance
with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable shares
and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary shares
and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid.
The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between
the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject
to possible redemption was considered to be dividends paid to the public stockholders. As of June 30, 2021 and 2020, the Company has not
considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 3,050,000
and 3,050,000 shares in the calculation of diluted net loss per share, since the exercise of the warrants is contingent upon the occurrence
of future events and the inclusion of such warrants would be anti-dilutive and the Company did not have any other dilutive securities
and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company.
As a result, diluted loss per share is the same as basic loss per share for the period presented.
The net loss per share presented in the unaudited
condensed statement of operations is based on the following:
|
|
For the
Year
Ended
June 30,
|
|
|
For
the
Period from
August 12,
2019
(Inception)
through
June 30,
|
|
|
|
2021
|
|
|
2020
|
|
Net loss
|
|
$
|
(819,366
|
)
|
|
$
|
(34,625
|
)
|
Accretion of carrying value to redemption value
|
|
|
(4,485,864
|
)
|
|
|
-
|
|
Net loss including accretion of carrying value to redemption value
|
|
$
|
(5,305,230
|
)
|
|
$
|
(34,625
|
)
|
|
|
For the Year Ended
June 30, 2021
|
|
|
For the Period from August 12,
2019 (Inception) through
June 30, 2020
|
|
|
|
Redeemable
Common Stock
|
|
|
Non-
Redeemable
Common Stock
|
|
|
Redeemable Common Stock
|
|
|
Non-Redeemable Common Stock
|
|
Basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerators:
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net loss including carrying value to redemption value
|
|
$
|
(2,877,607
|
)
|
|
$
|
(2,427,623
|
)
|
|
$
|
-
|
|
|
$
|
(34,625
|
)
|
Accretion of carrying value to redemption value
|
|
|
4,485,864
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Allocation of net income (loss)
|
|
$
|
1,608,257
|
|
|
$
|
(2,427,623
|
)
|
|
$
|
-
|
|
|
$
|
(34,625
|
)
|
Denominators:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding
|
|
|
1,843,579
|
|
|
|
1,555,290
|
|
|
|
-
|
|
|
|
1,250,000
|
|
Basic and diluted net income (loss) per share
|
|
$
|
0.87
|
|
|
$
|
(1.56
|
)
|
|
$
|
-
|
|
|
$
|
(0.03
|
)
|
Parties, which can be a corporation or individual,
are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant
influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are
subject to common control or common significant influence.
●
|
Recent accounting pronouncements
|
The Company has considered all new accounting
pronouncements and has concluded that there are no new pronouncements that may have a material impact on the results of operations, financial
condition, or cash flows, based on the current information.
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
NOTE 3 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL
STATEMENTS
On April 12, 2021, the Acting Director of the
Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement regarding the accounting and reporting
considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting
Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”).
Specifically, the SEC Statement focused on certain provisions that provided for potential changes to the settlement amounts dependent
upon the characteristics of the holder of the warrant, which terms are similar to those contained in the warrant agreement governing the
Company’s warrants.
The Company previously accounted for its outstanding
Public Warrants (as defined in Note 5) issued in connection with its Public Offering (as defined in Note 5) as derivative liabilities.
The Company’s management evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts
in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial
instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the
warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common
stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to
the fair value of the warrant. After the evaluation of the provisions of the Public Warrants, the Company concluded that the Public
Warrants are indexed to the Company’s common shares in the manner contemplated by ASC Section 815-40-15 and should be classified
as components of equity. The Company previously accounted the Public Warrants as derivative liabilities instead of components of equity
did not have significant impact on the Company’s previously issued statements of operations and cash flows.
In addition, in preparation of the Company’s
audited financial statements as of and for the year ended June 30, 2021, the Company concluded it should restate its consolidated financial
statements to classify all common stock subject to possible redemption in temporary equity. In accordance with the SEC and its staff’s
guidance on redeemable equity instruments, ASC Topic 480, Distinguishing Liabilities from Equity (ASC 480), paragraph 10-S99, redemption
provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent
equity. The Company had previously classified a portion of its common stock in permanent equity. Although the Company did not specify
a maximum redemption threshold, its charter provides that currently, the Company will not redeem its public shares in an amount that would
cause its net tangible assets to be less than $5,000,001. The Company considered that the threshold would not change the nature of the
underlying shares as redeemable and thus would be required to be disclosed outside equity. As a result, the Company restated its previously
filed financial statements to classify all common stock as temporary equity and to recognize accretion from the initial book value to
redemption value at the time of its Initial Public Offering and in accordance with ASC 480. The change in the carrying value of redeemable
shares of common stock resulted in charges against additional paid-in capital and accumulated deficit.
The following tables summarize the effect of the
restatement on each financial statement line item as of the dates, and for the period, indicated:
Adjustment #1 refer to reclassification of public
warrants from warrant liabilities to equity component.
Adjustment
#2 refer to reclassification of all public shares to temporary equity.
|
|
As
Previously
Reported
|
|
|
Adjustments #1
|
|
|
Adjustments #2
|
|
|
As
Restated
|
|
Balance sheet as of March 4, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant Liabilities
|
|
|
7,220,000
|
|
|
|
(6,450,000
|
)
|
|
|
-
|
|
|
|
770,000
|
|
Total Liabilities
|
|
|
9,356,654
|
|
|
|
(6,450,000
|
)
|
|
|
-
|
|
|
|
2,906,654
|
|
Ordinary Shares Subject to Possible Redemption
|
|
|
37,586,880
|
|
|
|
-
|
|
|
|
12,413,120
|
|
|
|
50,000,000
|
|
Ordinary Shares
|
|
|
5,318,526
|
|
|
|
-
|
|
|
|
(2,563,526
|
)
|
|
|
2,755,000
|
|
Accumulated deficit
|
|
|
(318,522
|
)
|
|
|
6,450,000
|
|
|
|
(9,849,594
|
)
|
|
|
(3,718,116
|
)
|
Total shareholders’ equity (deficit)
|
|
|
5,000,004
|
|
|
|
6,450,000
|
|
|
|
(12,413,120
|
)
|
|
|
(963,116
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet as of March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities
|
|
|
8,210,000
|
|
|
|
(7,430,000
|
)
|
|
|
-
|
|
|
|
780,000
|
|
Total liabilities
|
|
|
10,237,481
|
|
|
|
(7,430,000
|
)
|
|
|
-
|
|
|
|
2,807,481
|
|
Ordinary shares subject to possible redemption
|
|
|
43,499,246
|
|
|
|
-
|
|
|
|
14,000,754
|
|
|
|
57,500,000
|
|
Ordinary shares
|
|
|
5,486,160
|
|
|
|
-
|
|
|
|
(2,731,160
|
)
|
|
|
2,755,000
|
|
Retained earnings (accumulated deficit)
|
|
|
(487,244
|
)
|
|
|
7,430,000
|
|
|
|
(11,269,594
|
)
|
|
|
(4,326,838
|
)
|
Total shareholders’ equity (deficit)
|
|
|
5,000,008
|
|
|
|
7,430,000
|
|
|
|
(14,000,754
|
)
|
|
|
(1,570,746
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet as of June 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares subject to possible redemption
|
|
|
50,547,744
|
|
|
|
-
|
|
|
|
6,952,256
|
|
|
|
57,500,000
|
|
Ordinary shares
|
|
|
5,857,662
|
|
|
|
-
|
|
|
|
(3,102,662
|
)
|
|
|
2,755,000
|
|
Accumulated deficit
|
|
|
(853,991
|
)
|
|
|
-
|
|
|
|
(3,849,594
|
)
|
|
|
(4,703,585
|
)
|
Total shareholders’ equity (deficit)
|
|
|
5,000,005
|
|
|
|
-
|
|
|
|
(6,952,256
|
)
|
|
|
(1,952,251
|
)
|
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
|
|
As
Previously
Reported
|
|
|
Adjustments #1
|
|
|
Adjustments #2
|
|
|
As
Restated
|
|
Statement of operations for the three months ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liabilities
|
|
|
(20,000
|
)
|
|
|
10,000
|
|
|
|
-
|
|
|
|
(10,000
|
)
|
Net loss
|
|
|
(221,018
|
)
|
|
|
10,000
|
|
|
|
-
|
|
|
|
(211,018
|
)
|
Basic and diluted weighted average shares outstanding, non-redeemable ordinary shares
|
|
|
1,962,294
|
|
|
|
-
|
|
|
|
(406,961
|
)
|
|
|
1,555,333
|
|
Basic and diluted net loss per share
|
|
|
(0.11
|
)
|
|
|
-
|
|
|
|
(1.25
|
)
|
|
|
(1.36
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of operations for the nine months ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liabilities
|
|
|
(20,000
|
)
|
|
|
10,000
|
|
|
|
-
|
|
|
|
(10,000
|
)
|
Net loss
|
|
|
(452,619
|
)
|
|
|
10,000
|
|
|
|
-
|
|
|
|
(442,619
|
)
|
Basic and diluted weighted average shares outstanding, non-redeemable ordinary shares
|
|
|
1,609,961
|
|
|
|
-
|
|
|
|
(133,757
|
)
|
|
|
1,476,204
|
|
Basic and diluted net loss per share
|
|
|
(0.28
|
)
|
|
|
-
|
|
|
|
(1.91
|
)
|
|
|
(2.19
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of operations for the year ended June 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, subject to possible redemption
|
|
|
1,638,590
|
|
|
|
-
|
|
|
|
204,989
|
|
|
|
1,843,579
|
|
Basic and diluted net loss per share
|
|
|
0.00
|
|
|
|
-
|
|
|
|
0.87
|
|
|
|
0.87
|
|
Basic and diluted weighted average shares outstanding, non-redeemable ordinary shares
|
|
|
1,771,207
|
|
|
|
-
|
|
|
|
(215,917
|
)
|
|
|
1,555,290
|
|
Basic and diluted net loss per share
|
|
|
(0.46
|
)
|
|
|
-
|
|
|
|
(1.10
|
)
|
|
|
(1.56
|
)
|
|
|
As
|
|
|
|
|
|
|
|
|
|
|
|
|
Previously
|
|
|
Adjustment
|
|
|
Adjustments
|
|
|
As
|
|
|
|
Reported
|
|
|
#1
|
|
|
#2
|
|
|
Revised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of cash flows for the nine months ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liabilities
|
|
$
|
20,000
|
|
|
$
|
(10,000
|
)
|
|
$
|
-
|
|
|
$
|
10,000
|
|
Net loss
|
|
|
(452,619
|
)
|
|
|
10,000
|
|
|
|
-
|
|
|
|
(442,619
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of cash flows for the year ended June 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial classification of shares subject to redemption
|
|
|
51,086,880
|
|
|
|
-
|
|
|
|
5,731,301
|
|
|
|
56,818,181
|
|
Reclassification of shares subject to redemption
|
|
|
539,136
|
|
|
|
-
|
|
|
|
(539,136
|
)
|
|
|
-
|
|
Allocation of offering costs to ordinary shares subject to redemption
|
|
|
-
|
|
|
|
-
|
|
|
|
3,804,045
|
|
|
|
3,804,045
|
|
Accretion of carrying value to redemption value
|
|
|
-
|
|
|
|
-
|
|
|
|
(4,485,864
|
)
|
|
|
(4,485,864
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statements of changes in shareholders’ deficit for the three and nine months ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of units in initial public offering – ordinary shares amount
|
|
$
|
50,080,000
|
|
|
$
|
-
|
|
|
$
|
3,570,306
|
|
|
$
|
53,650,306
|
|
Sale of units in initial public offering – total shareholders’ (deficit) equity
|
|
|
50,080,000
|
|
|
|
-
|
|
|
|
3,570,306
|
|
|
|
53,650,306
|
|
Initial classification of ordinary shares subject to possible redemption – ordinary shares amount
|
|
|
(36,616,880
|
)
|
|
|
-
|
|
|
|
(20,201,301
|
)
|
|
|
(56,818,181
|
)
|
Initial classification of ordinary shares subject to possible redemption – total shareholders’ (deficit) equity
|
|
|
(36,616,880
|
)
|
|
|
-
|
|
|
|
(20,201,301
|
)
|
|
|
(56,818,181
|
)
|
Change in fair value of ordinary shares subject to possible redemption – ordinary shares amount
|
|
|
(6,882,366
|
)
|
|
|
-
|
|
|
|
6,882,366
|
|
|
|
-
|
|
Change in fair value of ordinary shares subject to possible redemption – total shareholders’ (deficit) equity
|
|
|
(6,882,366
|
)
|
|
|
-
|
|
|
|
6,882,366
|
|
|
|
-
|
|
Allocation of offering costs to ordinary shares subject to redemption
|
|
|
-
|
|
|
|
-
|
|
|
|
3,804,045
|
|
|
|
3,804,045
|
|
Allocation of offering costs to ordinary shares subject to redemption – total shareholders’ (deficit) equity
|
|
|
-
|
|
|
|
-
|
|
|
|
3,804,045
|
|
|
|
3,804,045
|
|
Accretion of carrying value to redemption value
|
|
|
-
|
|
|
|
-
|
|
|
|
(4,485,864
|
)
|
|
|
(4,485,864
|
)
|
Accretion of carrying value to redemption value – total shareholders’ (deficit) equity
|
|
|
-
|
|
|
|
-
|
|
|
|
(4,485,864
|
)
|
|
|
(4,485,864
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of changes in shareholders’ deficit for the year ended June 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial classification of ordinary shares subject to possible redemption – ordinary shares amount
|
|
|
(51,086,880
|
)
|
|
|
-
|
|
|
|
(5,731,301
|
)
|
|
|
(56,818,181
|
)
|
Initial classification of ordinary shares subject to possible redemption – total shareholders’ (deficit) equity
|
|
|
(51,086,880
|
)
|
|
|
-
|
|
|
|
(5,731,301
|
)
|
|
|
(56,818,181
|
)
|
Change in fair value of ordinary shares subject to possible redemption – ordinary shares amount
|
|
|
539,136
|
|
|
|
-
|
|
|
|
539,136
|
|
|
|
-
|
|
Change in fair value of ordinary shares subject to possible redemption – total shareholders’ (deficit) equity
|
|
|
539,136
|
|
|
|
-
|
|
|
|
539,136
|
|
|
|
-
|
|
Allocation of offering costs to ordinary shares subject to redemption
|
|
|
-
|
|
|
|
-
|
|
|
|
3,804,045
|
|
|
|
3,804,045
|
|
Allocation of offering costs to ordinary shares subject to redemption – total shareholders’ (deficit) equity
|
|
|
-
|
|
|
|
-
|
|
|
|
3,804,045
|
|
|
|
3,804,045
|
|
Accretion of carrying value to redemption value
|
|
|
-
|
|
|
|
-
|
|
|
|
(4,485,864
|
)
|
|
|
(4,485,864
|
)
|
Accretion of carrying value to redemption value – total shareholders’ (deficit) equity
|
|
|
-
|
|
|
|
-
|
|
|
|
(4,485,864
|
)
|
|
|
(4,485,864
|
)
|
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
NOTE 4 — CASH AND INVESTMENT HELD IN
TRUST ACCOUNT
As of June 30, 2021, investment securities in
the Company’s Trust Account consisted of $57,496,825 in United States Treasury Bills and $2,326 in cash. As of June 30, 2020, the
Company did not have any balance in its Trust Account. The Company classifies its United States Treasury securities as available-for-sale.
Available-for-sale marketable securities are recorded at their estimated fair value on the accompanying June 30, 2021 balance sheet. The
carrying value, including gross unrealized holding gain as other comprehensive income and fair value of held to marketable securities
on June 30, 2021 are as follows:
|
|
Carrying Value
as of June 30,
2021
|
|
|
Gross Unrealized
Holding loss
|
|
|
Fair Value as of
June 30,
2021
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale marketable securities
|
|
|
|
|
|
|
|
|
|
U.S. Treasury Securities
|
|
$
|
57,500,491
|
|
|
$
|
(3,666
|
)
|
|
$
|
57,496,825
|
|
|
|
Carrying Value
as of June 30,
2020
|
|
|
Gross Unrealized
Holding loss
|
|
|
Fair Value as of
June 30,
2020
|
|
Available-for-sale marketable securities
|
|
|
|
|
|
|
|
|
|
U.S. Treasury Securities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
NOTE 5 — PUBLIC OFFERING
On March 4, 2021, the Company sold 5,000,000 units
at a price of $10.00 per Public Unit in the Public Offering. Each Public Unit consists of one ordinary share of the Company, no par value
per share (the “Public Shares”), one right (the “Public Rights”) and one redeemable warrant (the “Public
Warrants”). Each Public Right entitles the holder to receive one-tenth (1/10) of an ordinary share upon consummation of an initial
Business Combination. Each Public Warrant entitles the holder to purchase one-half (1/2) of one ordinary share, and each ten rights entitle
the holder thereof to receive one ordinary share at the closing of a business combination. In addition, the Company has granted Maxim
Group LLC, the underwriter of the Public Offering, a 45-day option to purchase up to 750,000 Public Units solely to cover over-allotments.
On March 9, 2021, the underwriters exercised the option in full of 750,000 units at a price of $10.00 per unit.
If the Company does not complete its Business
Combination within the necessary time period described in Note 1, the Public Rights will expire and be worthless. Since the Company is
not required to net cash settle the Rights and the Rights are convertible upon the consummation of an initial Business Combination, the
Management determined that the Rights are classified within shareholders’ equity as “Additional paid-in capital” upon
their issuance in accordance with ASC 815-40. The proceeds from the sale are allocated to Public Shares and Rights based on the relative
fair value of the securities in accordance with ASC 470-20-30. The value of the Public Shares and Rights will be based on the closing
price paid by investors.
The Company paid an upfront underwriting discount
of $1,437,500 (2.5%) of the per unit offering price to the underwriter at the closing of the Public Offering, with an additional fee of
$2,012,500 (the “Deferred Discount”) of 3.5% of the gross offering proceeds payable upon the Company’s completion of
the Business Combination. The Deferred Discount will become payable to the underwriter from the amounts held in the Trust Account solely
in the event the Company completes its Business Combination. In the event that the Company does not close the Business Combination, the
underwriter has waived its right to receive the Deferred Discount. The underwriter is not entitled to any interest accrued on the Deferred
Discount.
On March 5, 2021, Maxim Group, LLC exercised their
right to acquire option to purchase up to a total of 287,500 units (the “Unit Purchase Option”) at $11.50 per unit for $100.
As of June 30, 2021, the Unit Purchase Option has not been exercised.
NOTE 6 – PRIVATE PLACEMENT
Simultaneously with the closing of the Public
Offering, the Company consummated a private placement of 350,000 Private Units, at $10.00 per unit, purchased by the Sponsor.
The Private Units are identical to the units sold
in the Public Offering except that the private warrants will be non-redeemable and may be exercised on a cashless basis.
NOTE 7 – RELATED PARTY TRANSACTIONS
Founder and Additional Shares
In August 2019, 10,000 shares were sold. In September
2020, the Company issued another 1,427,500 ordinary shares resulting in an aggregate of 1,437,500 ordinary shares (the “Founder
Shares”) outstanding to our initial shareholders, for an aggregate purchase price of $25,000, or approximately $0.017 per share.
All share and per share information have been retroactively adjusted to reflect the share split. In January 2021, the Sponsor transferred
300,000 of its insider shares to Golden Bridge Holding, LLC, 606,061 shares to Scienjoy Inc., 30,000 shares to Lucky Link International
Limited and 60,606 shares to Can Wu.
The initial shareholders have agreed not to transfer,
assign or sell any of the founder shares (except to certain permitted transferees) until (1) with respect to 50% of the founder shares,
the earlier of six months after the completion of a Business Combination and the date on which the closing price of the ordinary shares
equals or exceeds $12.50 per share for any 20 trading days within any 30-trading day period commencing after a Business Combination and
(2) with respect to the remaining 50% of the founder shares, six months after the completion of a Business Combination, or earlier, in
either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, share exchange or other similar transaction
which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other
property.
Amounts due to related parties
As of June 30, 2021 and 2020, the balances due
to related parties were $9,981 and 79,532, respectively. The balance is unsecured, interest-free and has no fixed terms of repayment.
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
Administrative Services Agreement
The Company is obligated, commencing from June
1, 2020, to pay Golden Bridge Capital Limited, which is also owned by Mr. Jining Li, the Company’s director and also the affiliate
of the Sponsor, a monthly fee of $10,000 for general and administrative services. This agreement will terminate upon completion of the
Company’s business combination or the liquidation of the trust account to public shareholders.
Related Party Extensions Loan
The Company will have until 12 months from the
consummation of the Initial Public Offering to consummate the initial Business Combination. However, if the Company anticipates that the
Company may not be able to consummate the initial Business Combination within 12 months, the Company may, but is not obligated to, extend
the period of time to consummate a Business Combination three times by an additional three months each time (for a total of up to 21 months
to complete a Business Combination). Pursuant to the terms of our amended and restated memorandum and articles of association and the
trust agreement entered into between the Company and Continental Stock Transfer & Trust Company, LCC, in order to extend the time
available for the Company to consummate the initial Business Combination, the Company’s insiders or their affiliates or designees,
upon five days advance notice prior to the applicable deadline, must deposit into the Trust Account $575,000 ($0.10 per share), on or
prior to the date of the applicable deadline. The insiders will receive a non-interest bearing, unsecured promissory note equal to the
amount of any such deposit that will not be repaid in the event that the Company is unable to close a Business Combination unless there
are funds available outside the Trust Account to do so. Such notes would either be paid upon consummation of the initial Business Combination,
or, at the lender’s discretion, converted upon consummation of the Business Combination into additional private units at a price
of $10.00 per unit.
Director’s Remuneration
The Company is obligated, commencing from June
1, 2020, to pay Yongsheng Liu, which is the Company’s CEO, a monthly fee of HK$50,000 for his service to the Company.
NOTE 8 – SHAREHOLDER’S DEFICIT
Ordinary Shares
The Company is authorized to issue unlimited ordinary
shares with no par value. Holders of the Company’s ordinary shares are entitled to one vote for each share. At June 30, 2021, there
were 1,816,250 ordinary shares issued and outstanding (excluding 5,750,000 shares subject to redemption). At June 30, 2020, there were
1,437,500 ordinary shares issued and outstanding (excluding 0 shares subject to redemption).
Accumulated Other Comprehensive Income (Loss)
The table below presents the changes in accumulated
other comprehensive income (loss) (“AOCI”), including the reclassification out of AOCI.
|
|
Available-for-sale
securities
|
|
Balance as of July 1, 2020
|
|
$
|
-
|
|
Other comprehensive loss before reclassifications
|
|
|
(849
|
)
|
Amounts reclassified from AOCI into interest income
|
|
|
(2,817
|
)
|
Balance as of June 30, 2021
|
|
$
|
(3,666
|
)
|
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
Warrants
Each public warrant entitles the holder thereof
to purchase one-half (1/2) of one ordinary share at a price of $11.50 per full share, subject to adjustment as described in this prospectus.
Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares. This means that only
an even number of warrants may be exercised at any given time by a warrant holder.
No public warrants will be exercisable for cash
unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the warrants
and a current prospectus relating to such ordinary shares. It is the Company’s current intention to have an effective and current
registration statement covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to such ordinary
shares in effect promptly following consummation of an initial business combination.
Notwithstanding the foregoing, if a registration
statement covering the ordinary shares issuable upon exercise of the public warrants is not effective within 90 days following the consummation
of our initial business combination, public warrant holders may, until such time as there is an effective registration statement and during
any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to
an available exemption from registration under the Securities Act. In such event, each holder would pay the exercise price by surrendering
the warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares
underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value”
(defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the
ordinary shares for the 10 trading days ending on the day prior to the date of exercise. For example, if a holder held 300 warrants to
purchase 150 shares and the fair market value on the date prior to exercise was $15, that holder would receive 35 shares without the payment
of any additional cash consideration. If an exemption from registration is not available, holders will not be able to exercise their warrants
on a cashless basis.
The warrants will become exercisable on the later
of the completion of an initial business combination. The warrants will expire at 5:00 p.m., New York City time, on the fifth anniversary
of our completion of an initial business combination, or earlier upon redemption.
The Company may redeem the outstanding warrants
(including any outstanding warrants issued upon exercise of the unit purchase option issued to Maxim Group LLC), in whole and not in part,
at a price of $0.01 per warrant:
|
●
|
at any time while the Public Warrants are exercisable,
|
|
●
|
upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder,
|
|
●
|
if, and only if, the reported last sale price of the ordinary shares equals or exceeds $16.50 per share, for any 20 trading days within a 30 trading day period ending on the third trading day prior to the notice of redemption to Public Warrant holders, and
|
|
●
|
if, and only if, there is a current registration statement in effect with respect to the issuance of the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.
|
If the foregoing conditions are satisfied and
the Company would issue a notice of redemption, each warrant holder can exercise his, her or its warrant prior to the scheduled redemption
date. However, the price of the ordinary shares may fall below the $16.50 trigger price as well as the $11.50 warrant exercise price per
full share after the redemption notice is issued and not limit our ability to complete the redemption.
The redemption criteria for the warrants have
been established at a price which is intended to provide warrant holders a reasonable premium to the initial exercise price and provide
a sufficient differential between the then-prevailing share price and the warrant exercise price so that if the share price declines as
a result of our redemption call, the redemption will not cause the share price to drop below the exercise price of the warrants.
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
Rights
Except in cases where the Company is not the surviving
company in a Business Combination, each holder of a Public Right will automatically receive one-tenth (1/10) of an ordinary share upon
consummation of a Business Combination, even if the holder of a Public Right converted all ordinary shares held by him, her or it in connection
with a Business Combination or an amendment to the Company’s Amended and Restated Memorandum and Articles of Association with respect
to its pre-business combination activities. In the event that the Company will not be the surviving company upon completion of a Business
Combination, each holder of a Public Right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth
(1/10) of a share underlying each Public Right upon consummation of a Business Combination. No additional consideration will be required
to be paid by a holder of Public Rights in order to receive his, her or its additional ordinary shares upon consummation of a Business
Combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company).
If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the
definitive agreement will provide for the holders of Public Rights to receive the same per share consideration the holders of ordinary
shares will receive in the transaction on an as-converted into ordinary shares basis.
The Company will not issue fractional shares in
connection with an exchange of Public Rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed
in accordance with the applicable provisions of the British Virgin Islands law. As a result, the holders of the Public Rights must hold
rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a Business Combination. If the
Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust
Account, holders of Public Rights will not receive any of such funds with respect to their Public Rights, nor will they receive any distribution
from the Company’s assets held outside of the Trust Account with respect to such Public Rights, and the Public Rights will expire
worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the Public Rights upon consummation
of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights
may expire worthless.
NOTE 9 –
FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1:
|
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
|
Level 2:
|
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
|
|
|
Level 3:
|
Unobservable inputs based on the assessment of the assumptions that market participants would use in pricing the asset or liability.
|
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
The following
table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of
June 30, 2021, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
|
|
June 30,
|
|
|
Quoted Prices In Active Markets
|
|
|
Significant Other Observable Inputs
|
|
|
Significant Other Unobservable Inputs
|
|
|
|
2021
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
Description
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury Securities held in Trust Account*
|
|
$
|
57,496,825
|
|
|
$
|
57,496,825
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities
|
|
$
|
740,000
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
740,000
|
|
*
|
included in cash and investments held in trust account on the Company’s balance sheet.
|
The private warrants are accounted for as liabilities
in accordance with ASC 815-40 and are presented within warrant liabilities on the consolidated balance sheets.
The Company established the initial fair value
for the private warrants at $770,000 on March 4, 2021, the date of the Company’s Initial Public Offering, using a Black-Scholes
model. The Company allocated the proceeds received from the sale of Private Units, first to the private warrants based on their fair values
as determined at initial measurement, with the remaining proceeds recorded as ordinary shares subject to possible redemption, and ordinary
shares based on their relative fair values recorded at the initial measurement date. The warrants were classified as Level 3 at the initial
measurement date due to the use of unobservable inputs.
The key inputs into the binomial model and Black-Scholes
model were as follows at their measurement dates:
|
|
June 30,
2021
|
|
|
March 4,
2021 (Initial
measurement)
|
|
Input
|
|
|
|
|
|
|
Share price
|
|
$
|
9.8
|
|
|
$
|
10.00
|
|
Risk-free interest rate
|
|
|
0.87
|
%
|
|
|
0.77
|
%
|
Volatility
|
|
|
55
|
%
|
|
|
56
|
%
|
Exercise price
|
|
$
|
11.50
|
|
|
$
|
11.50
|
|
Warrant life
|
|
|
5 years
|
|
|
|
5 years
|
|
As of June 30, 2021, the aggregate value of the
Private Warrants was $0.74 million. The change in fair value from March 4, 2021 to June 30, 2021 was approximately $(30,000).
To the extent that valuation is based on models
or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Because of the
inherent uncertainty of valuation, those estimated values may be materially higher or lower than the values that would have been used
had a ready market for the investments existed. Accordingly, the degree of judgment exercised by the Company in determining fair value
is greatest for investments categorized in Level 3. Level 3 financial liabilities consist of the Private Warrant liability for which there
is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes
in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates
or assumptions and recorded as appropriate.
NOTE 10 – COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
Management is currently evaluating the impact
of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect
on the Company’s future financial position, results of its operations and/or search for a target company, there has been a significant
impact as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments
that might result from the future outcome of this uncertainty.
GOLDENBRIDGE ACQUISITION
LIMITED
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
Registration Rights
The holders of the Founder Shares, the Private
Placement Warrants (and their underlying securities) and the warrants that may be issued upon conversion of the Working Capital Loans
(and their underlying securities) are entitled to registration rights pursuant to the registration rights agreement signed on the effective
date of the Public Offering. The holders of a majority of these securities are entitled to make up to two demands that the Company register
such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing
three months prior to the date on which these ordinary shares are to be released from escrow. The holders of a majority of the Private
Placement Warrants and warrants issued in payment of Working Capital Loans made to the Company (or underlying securities) can elect to
exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain
“piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business
Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Deferred Underwriter Compensation
The Company is committed to pay the Deferred Discount
of 3.5% of the gross offering proceeds, in the amount of $2,012,500 of the Public Offering, to the underwriter upon the Company’s
consummation of the Business Combination. The underwriter is not entitled to any interest accrued on the Deferred Discount, and has waived
its right to receive the Deferred Discount if the Company does not close a Business Combination.
Unit Purchase Option
The Company sold to Maxim for $100, an option
to purchase 287,500 units exercisable, at $11.50 per unit commencing at any time between the first and fifth anniversary of the effective
date of the registration statement relating to its initial public offering. The purchase option may be exercised for cash or on a cashless
basis, at the holder’s option, and expires on March 4, 2026. The option and the units, as well as the ordinary shares and warrants
to purchase ordinary shares that may be issued upon exercise of the option, have been deemed compensation by FINRA and are therefore subject
to a lock-up for a period of 180 days immediately following the effective date of the registration statement of which this prospectus
forms a part or the commencement of sales in the Public Offering pursuant to Rule 5110(g)(1) of FINRA’s Rules, during which time
the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale, derivative or put
or call transaction that would result in the economic disposition of the securities. Additionally, the option may not be sold, transferred,
assigned, pledged or hypothecated prior to March 4, 2022 except to any underwriters and selected dealer participating in the offering
and their bona fide officers or partners. The option grants to holders demand and “piggy back” rights for periods of five
and seven years, respectively, from the effective date of the registration statement of which forms a part with respect to the registration
under the Securities Act of the securities directly and indirectly issuable upon exercise of the option. We will bear all fees and expenses
attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise
price and number of units issuable upon exercise of the option may be adjusted in certain circumstances including in the event of a stock
dividend, or recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of ordinary
shares at a price below its exercise price.
Right of First Refusal
Subject to certain conditions, the Company granted
Maxim, for a period of 15 months after the date of the consummation of the business combination, a right of first refusal to act as lead
underwriters or minimally as a co-manager, with at least 30% of the economics; or, in the case of a three-handed deal, 30% of the economics,
for any and all future public and private equity and debt offerings. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first
refusal shall not have a duration of more than three years from the effective date of the registration statement of which this prospectus
forms a part.
NOTE 11 – SUBSEQUENT EVENTS
In accordance with ASC Topic 855, “Subsequent
Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date
but before consolidated financial statements are issued, the Company has evaluated all events or transactions that occurred after June
30, 2021, up through the date the Company issued the consolidated financial statements.
On August 6, 2021 and August 25, 2021, the Company
formed two subsidiaries, PubCo and Merger Sub (as defined in Note 1), respectively, under the laws of the Cayman Island for the purpose
of effectuating the Business Combination.
On September 30, 2021, the Company entered into
a definitive agreement or non-binding letter of intent to acquire a company, AgiiPlus Inc., (“AgiiPlus”). The aggregate consideration
to be paid to AgiiPlus shareholders for the Acquisition Merger is $520 million, payable in the form of a number of newly issued Purchaser
Ordinary Shares (the “Closing Payment Shares”) valued at the $10.00 per share. Under the Merger Agreement, 1,000,000 shares
of the Closing Payment Shares (“Escrow Shares”) to be issued will be held in escrow for a period of 6 months after the closing
to satisfy indemnification obligations.
F-21
Goldenbridge Acquisition Limited (the “Company,” “we”,
“our” or “us”) is filing this Annual Report on Form 10-K/A (Amendment No. 1), or this Annual Report,
to amend its Annual Report on Form 10-K for the year ended June 30, 2021, originally filed with the Securities and Exchange Commission,
or the SEC, on September 1, 2021, or the Original Filing, to restate our financial statements for the year ended June 30, 2021. As a result,
this Amendment No. 1 describes the restatement and its impact on previously reported amounts.Background of RestatementOn April 12, 2021, the Acting Director of the
Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement regarding the accounting and reporting
considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting
Considerations for Warrants Issued by Special Purpose Acquisition Companies(“SPACs”)” (the “SEC Statement”).
Specifically, the SEC Statement focused on certain provisions that provided for potential changes to the settlement amounts dependent
upon the characteristics of the holder of the warrant, which terms are similar to those contained in the warrant agreement governing the
Company’s warrants. As a result of the SEC Statement, on December 21, 2021, the Company reevaluated the accounting treatment of
the 5,750,000 warrants that were issued in the Initial Public Offering (the “Public Warrants”). The Company previously accounted
for the Public Warrants as components of derivative liabilities.As a result of the above, the Company should have
classified the Public warrants as component of equity in its previously issued financial statements. The Company’s accounting for
the Public warrants as derivative liabilities instead of as components of equity did not have any effect on the Company’s previously
reported operating expenses or cash.In addition, in accordance with the SEC and
its staff’s guidance on redeemable equity instruments, ASC Topic 480, Distinguishing Liabilities from Equity (ASC 480),
paragraph 10-S99, redemption provisions not solely within the control of the Company require ordinary share subject to redemption to
be classified outside of permanent equity. The Company had previously classified a portion of its ordinary share in permanent
equity. Although the Company did not specify a maximum redemption threshold, its charter provides that currently, the Company will
not redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001. The Company
considered that the threshold would not change the nature of the underlying shares as redeemable and thus would be required to be
disclosed outside equity. As a result, the Company’s previously issued (i) audited balance sheet as of March 4, 2021 included
in the Company’s Current Report on Form 8-K/A filed with the SEC on May 17, 2021, (ii) audited financial statements as of June
30, 2021 and for the year ended June 30, 2021 filed with the SEC on September 1, 2021, (iii) unaudited interim financial statements
as of March 31, 2021 and for the three and nine months ended March 31, 2021 included in the Company’s Quarterly Report on Form
10-Q filed with the SEC on May 17, 2021 (collectively, the “Affected Periods”), in each case, should be corrected to all
of the Public Shares as temporary equity and should no longer be relied upon.In connection with the restatement, the Company’s
management reassessed the effectiveness of its disclosure controls and procedures for the periods affected by the restatement. As a result
of that reassessment, the Company’s management determined that its disclosure controls and procedures for such periods were not
effective due to two material weaknesses in internal control over financial reporting related to the classification of the Company’s
warrants as components of equity instead of as derivative liabilities and the allocation and treatment of the initial transaction costs
of the initial public offering. For more information, see Item 9A included in this Annual Report on Form 10-K/A.The Company has reflected these corrections in its Quarterly Report
on Form 10-Q for the quarterly period ended September 30, 2021, filed with SEC on November 15, 2021 (the “November 2021 Form 10-Q”).
The Company does not expect the changes described above to have any impact on its cash position or the balance held in the trust account.
The Company has not amended its previously filed Quarterly Reports on Form 10-Q or Current Reports on Form 8-K for the period affected
by the restatement. The financial information that has been previously filed or otherwise reported for these periods is superseded by
the information in this Annual Report on Form 10-K/A, and the financial statements and related financial information contained in such
previously filed reports should no longer be relied upon.The restatement is more fully described in Note 2 of the notes to the
consolidated financial statements included herein.Items Amended in this Amendment No. 1This Amendment No. 1 presents the Original Filling, amended and
restated with modifications as necessary to reflect the restatements.The following items have been amended to reflect the restatement:Part I, Item 1A. Risk FactorsPart II, Item 7. Management’s Discussion and Analysis
of Financial Condition and Results of OperationsPart II, Item 8. Financial Statements And Supplementary DataPart II, Item 9A. Controls and ProceduresIn addition, the Company’s Chief Executive Officer and Chief
Financial Officer have provided new certifications dated as of the date of this filing in connection with this Amendment No. 1 (Exhibits
[*]).Except as described above, this Amendment No. 1
does not amend, update or change any other items or disclosures in the Original Filing and does not purport to reflect any information
or events subsequent to the filing thereof. As such, this Amendment No. 1 speaks only as of the date the Original Filing was filed,
and we have not undertaken herein to amend, supplement or update any information contained in the Original Filing to give effect to any
subsequent events. Accordingly, this Amendment No. 1 should be read in conjunction with our filings made with the SEC subsequent
to the filing of the Original Filing, including any amendment to those filings.
Unlimited
Unlimited
--06-30
FY
0001822792
00-0000000
0001822792
2020-07-01
2021-06-30
0001822792
2021-12-14
0001822792
2020-12-31
0001822792
2021-06-30
0001822792
2020-06-30
0001822792
us-gaap:CommonStockMember
2021-06-30
0001822792
us-gaap:CommonStockMember
2020-06-30
0001822792
2019-08-12
2020-06-30
0001822792
us-gaap:CommonStockMember
2019-08-11
0001822792
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-08-11
0001822792
us-gaap:RetainedEarningsMember
2019-08-11
0001822792
2019-08-11
0001822792
us-gaap:CommonStockMember
2019-08-12
2020-06-30
0001822792
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-08-12
2020-06-30
0001822792
us-gaap:RetainedEarningsMember
2019-08-12
2020-06-30
0001822792
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-06-30
0001822792
us-gaap:RetainedEarningsMember
2020-06-30
0001822792
us-gaap:CommonStockMember
2020-07-01
2021-06-30
0001822792
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-07-01
2021-06-30
0001822792
us-gaap:RetainedEarningsMember
2020-07-01
2021-06-30
0001822792
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-06-30
0001822792
us-gaap:RetainedEarningsMember
2021-06-30
0001822792
us-gaap:SubsequentEventMember
2021-09-30
0001822792
us-gaap:SubsequentEventMember
2021-09-01
2021-09-30
0001822792
2021-09-01
2021-09-30
0001822792
gbrg:BusinessCombinationMember
2021-06-30
0001822792
us-gaap:IPOMember
2021-06-30
0001822792
gbrg:TrustAccountMember
2020-07-01
2021-06-30
0001822792
gbrg:BusinessCombinationMember
2020-07-01
2021-06-30
0001822792
2019-07-01
2020-06-30
0001822792
us-gaap:IPOMember
2020-07-01
2021-06-30
0001822792
us-gaap:PrivatePlacementMember
2020-07-01
2021-06-30
0001822792
gbrg:CVSXLimitedPubCoMember
2020-07-01
2021-06-30
0001822792
gbrg:SmartCVSLimitedMergerSubMember
2020-07-01
2021-06-30
0001822792
gbrg:RedeemableOrdinarySharesMember
2020-07-01
2021-06-30
0001822792
gbrg:NonRedeemableOrdinarySharesMember
2020-07-01
2021-06-30
0001822792
gbrg:RedeemableOrdinarySharesMember
2019-07-01
2020-06-30
0001822792
gbrg:NonRedeemableOrdinarySharesMember
2019-07-01
2020-06-30
0001822792
srt:ScenarioPreviouslyReportedMember
2021-03-04
0001822792
gbrg:RevisionOfPriorPeriodAdjustment1Member
2021-03-04
0001822792
srt:RestatementAdjustmentMember
2021-03-04
0001822792
gbrg:AsRevisedMember
2021-03-04
0001822792
srt:ScenarioPreviouslyReportedMember
2021-03-31
0001822792
gbrg:RevisionOfPriorPeriodAdjustment1Member
2021-03-31
0001822792
srt:RestatementAdjustmentMember
2021-03-31
0001822792
gbrg:AsRevisedMember
2021-03-31
0001822792
srt:ScenarioPreviouslyReportedMember
2021-06-30
0001822792
gbrg:RevisionOfPriorPeriodAdjustment1Member
2021-06-30
0001822792
srt:RestatementAdjustmentMember
2021-06-30
0001822792
gbrg:AsRevisedMember
2021-06-30
0001822792
srt:ScenarioPreviouslyReportedMember
2021-01-01
2021-03-31
0001822792
gbrg:RevisionOfPriorPeriodAdjustment1Member
2021-01-01
2021-03-31
0001822792
srt:RestatementAdjustmentMember
2021-01-01
2021-03-31
0001822792
gbrg:AsRevisedMember
2021-01-01
2021-03-31
0001822792
srt:ScenarioPreviouslyReportedMember
2020-07-01
2021-03-31
0001822792
gbrg:RevisionOfPriorPeriodAdjustment1Member
2020-07-01
2021-03-31
0001822792
srt:RestatementAdjustmentMember
2020-07-01
2021-03-31
0001822792
gbrg:AsRevisedMember
2020-07-01
2021-03-31
0001822792
srt:ScenarioPreviouslyReportedMember
2020-07-01
2021-06-30
0001822792
gbrg:RevisionOfPriorPeriodAdjustment1Member
2020-07-01
2021-06-30
0001822792
srt:RestatementAdjustmentMember
2020-07-01
2021-06-30
0001822792
gbrg:AsRevisedMember
2020-07-01
2021-06-30
0001822792
us-gaap:USTreasurySecuritiesMember
2021-06-30
0001822792
us-gaap:USTreasurySecuritiesMember
2020-07-01
2021-06-30
0001822792
us-gaap:USTreasurySecuritiesMember
2020-06-30
0001822792
us-gaap:USTreasurySecuritiesMember
2019-07-01
2020-06-30
0001822792
us-gaap:IPOMember
2021-03-01
2021-03-04
0001822792
us-gaap:IPOMember
2021-03-04
0001822792
2021-03-01
2021-03-04
0001822792
gbrg:MaximGroupLLCMember
us-gaap:OverAllotmentOptionMember
2021-03-01
2021-03-04
0001822792
gbrg:MaximGroupLLCMember
2021-03-01
2021-03-09
0001822792
gbrg:MaximGroupLLCMember
2021-03-01
2021-03-05
0001822792
gbrg:MaximGroupLLCMember
2021-03-05
0001822792
us-gaap:PrivatePlacementMember
2021-06-30
0001822792
2019-08-02
2019-08-31
0001822792
2020-09-02
2020-09-30
0001822792
2020-09-30
0001822792
gbrg:GoldenBridgeHoldingLLCMember
2021-01-01
2021-01-31
0001822792
gbrg:ScienjoyIncMember
2021-01-01
2021-01-31
0001822792
gbrg:LuckyLinkInternationalLimitedMember
2021-01-01
2021-01-31
0001822792
gbrg:CanWuMember
2021-01-01
2021-01-31
0001822792
2020-05-25
2020-06-01
0001822792
us-gaap:CommonStockMember
2021-06-30
0001822792
us-gaap:CommonStockMember
2020-07-01
2021-06-30
0001822792
us-gaap:WarrantMember
2021-06-30
0001822792
us-gaap:WarrantMember
2020-07-01
2021-06-30
0001822792
us-gaap:PrivatePlacementMember
2021-03-04
0001822792
2021-03-06
2021-06-30
0001822792
us-gaap:FairValueInputsLevel1Member
2021-06-30
0001822792
us-gaap:FairValueInputsLevel2Member
2021-06-30
0001822792
us-gaap:FairValueInputsLevel3Member
2021-06-30
0001822792
2021-03-04
0001822792
2020-11-05
2021-03-04
0001822792
gbrg:BusinessCombinationMember
us-gaap:PrivatePlacementMember
2020-07-01
2021-06-30
0001822792
us-gaap:OverAllotmentOptionMember
2020-07-01
2021-06-30
0001822792
gbrg:AgiiPlusIncMember
us-gaap:SubsequentEventMember
2021-09-01
2021-09-30
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure